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CHAPTER 1 
ARTHRITIS AND INTESTINAL FLORA 
The etiology of rheumatoid arthritis (RA), a chronic joint inflammation, is 
unknown. A microbial involvement is suspected, but no particular microorganism has 
been incriminated. The human intestinal microflora is an abundant and continuous 
source of bacterial antigens and may be involved in the induction or maintenance of 
chronic joint inflammation. 
In this introductory chapter I shall describe the possible relationship between joint 
inflammation, bowel flora and intestinal disease. Clinical syndromes which suggest this 
relationship are presented. Characteristics of the human intestinal flora are described, 
together with bacterial cell wall structures and their immunological properties. Several 
aspects of the hypothesis that intestinal bacterial antigens may pass the intestinal wall 
and give rise to inflammatory symptoms at distant locations are discussed. Animal 
models developed to study joint inflammation, including two models which use bacterial 
antigens to elicit arthritis, are presented. Finally, the experimental work of this thesis is 
introduced. 
1.1 RHEUMATOID ARTHRITIS AND MICROORGANISMS 
Rheumatoid arthritis is a chronic disease in which a sterile joint inflammation is 
the most striking feature. About 1-2% of the human population is affected; it is a major 
cause of disability. One or several joints (hand, elbow, knee, foot, ankle, hip) may be 
affected, showing redness, swelling, pain, tenderness and morning stiffness, ultimately 
leading to joint deformation. The disease is systemic and present in multiple organs, but 
is expressed most apparently in the joints. The presentation of the disease is often 
insidious, but an acute attack of joint inflammation may also be the beginning of a 
protracted illness. Exacerbations and remissions are often seen. The onset of RA is most 
frequent during the third and fourth decade. The disease is more often seen in women 
than in men (ratio 3:1). An increased frequency of the HLA-DR4 antigen has been 
found in affected persons [1-3]. 
Histologically, a vasculitis of the joint synovium is a hallmark symptom of early 
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RA, followed by synovial infiltration with inflammatory cells and synovial proliferation. 
This leads to pannus formation, destruction of marginal cartilage and adjacent bone 
tissue, as can be seen on X-rays of affected joints. The disease may be accompanied by 
subcutaneous rheumatoid noduli and systemic manifestations of vasculitis, e.g. pulmonary 
fibrosis. Rheumatoid factor (antibodies against the Fe portion of IgG) can be detected 
in the serum of the majority of RA patients [1-3]. 
The etiology of RA still remains obscure, but a microbial involvement has been 
suspected for several decades [ 4-6]. Several microorganisms have been incriminated but 
no claim has stood the 'test of time [5-11]. 
Arguments for an nifectious etiology of RA are several: 
(a) septic arthritis has clinical similarities with RA; 
(b) some forms of sterile non-RA joint inflammations are related to infection 
elsewhere in the body; 
(c) in several animal models arthritis can be induced by bacterial cell wall antigens; 
(d) bacterial cell wall compounds have potent inflammatory properties; 
(e) RA patients show increased levels of serum antibodies against bacterial cell wall 
structures. 
Examples of microorganisms which have been incriminated in RA include difteroids 
[12], mycoplasmata [13,14], Clostridium perfringens [9,15], mycobacteria [15-18], several 
viruses such as parvovirus and Epstein-Barr virus [19], but these claims for etiological 
involvement appeared not to be convincing. 
The failure to pinpoint a particular microorganism as causative in RA caused a 
shift in the attention of researchers from an exogenous source of microbial antigens 
towards an endogenous one. The abundant resident microflora of the large bowel may 
well account for a continuous release of immunopotent bacterial antigens into the milieu 
interieur, resulting in induction or maintenance of chronic joint inflammation [6-
8,10,11,20-22]. It is supposed that bacterial fragments can pass the bowel wall, especially 
when the bowel wall is damaged by infection or inflammation. The immune system is 
exposed to these microbial substances, and immune complexes containing bacterial 
antigens [6] will be formed which are transposed to joints and other organs and give rise 
to inflammatory symptoms. It is known that the peptidoglycan part of Gram-positive 
bacteria is poorly biodegradable: streptococcal cell walls are protected from in vivo 
digestion by means of their polysaccharides [23]. Therefore, after entrance into the 
milieu interieur, bacterial debris may persist in tissues and contribute to chronicity of 
the inflammation. Distortion of the delicate balance between influx of bacterial antigens 
and their removal by the immune system may lead to accumulation of bacterial products 
in tissues [20,24]. 
The joint synovium has some special features which may explain why the joints 
are preferentially affected after systemic administration of microbial antigens. The 
synovium is highly vascularized, which is necessary for the nourishment and cleaning of 
the avascular cartilage. The absence of a basement membrane under the synovial lining 
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[25] might contribute to an intensified spread of bacterial antigens which arrive via 
synovial vessels. As discussed by Schulz et aL [24], there are several areas in the joint 
where highly vascularized tissues are adjacent to avascular tissues nourished by diffusion, 
e.g. perichondrium, peritendineum, periosteum and endo- and perimysium. The 
borderline between vascular and avascular tissues is supposed to be prone to antigen 
deposition, and there is ineffective antigen elimination due to an insufficient inflamma-
tory response of avascular tissue. These borderline localizations correspond with 
predilection sites for chronic rheumatoid inflammation in man and animals. The 
cartilage matrix may also act as a kind of reservoir in which antigens are dumped and 
from which they can be released [10,26]; liberation of antigens may lead to a flare of the 
joint disease. 
1.2 JOINT INFLAMMATION AND BOWEL DISEASE 
Bowel-related microbial etiology in RA is suggested by clinical and laboratory 
observations in a series of sterile joint inflammation diseases: 
(a) About 5-23% of patients with inflammatory bowel diseases (IBD), e.g. Crohn's 
disease (CD) and ulcerative colitis (UC) suffer from attacks of joint inflammation, 
especially of the major limb joints. The severity of the joint inflammations often parallels 
the activity of the intestinal disease; arthritis occurs more frequently in CD when the 
colon is affected [27]. Unlike RA, this bowel disease-associated joint inflammation rarely 
leads to erosions and irreversible joint damage; rheumatoid factor is usually negative 
[28-30]. In UC, colectomy results in complete remission of the arthritis. Surgical therapy 
for CD results in remission of arthritis in only 50% of cases [11]. The peripheral arthritis 
is not correlated with the HLA-B27 genotype whereas the spondylitis and sacroiliitis, 
which also may complicate IBD, are positively linked to HLA-B27 [11]. In contrast to 
peripheral arthritis, the axial arthritis is not alleviated by bowel surgery [29,30]. 
(b) In reactive arthritis, an acute, sterile oligoarthritis develops days to weeks after 
an infection at a remote site [31]. This is seen in Reiter's disease, in which an urethritis, 
probably caused by Chlamydia trachomatis or Ureoplasma urealyticum is complicated 
by a sterile arthritis and conjunctivitis [32]. The arthritis which complicates bowel 
infection by Salmonella, Shigella or Yersinia species is another example of reactive 
arthritis. In most cases, major joints of the extremities are affected. Viable micro-
organisms could not be demonstrated in synovial fluid. The majority of the patients are 
HLA-B27 positive. Molecular mimicry between bacterial surface antigens and antigenic 
determinants on host cells is assumed to be an underlying mechanism [31,32]. In two 
recent studies, Granfors et al. [33,34] showed the presence of Yersinia or Salmonella 
antigens in synovial cells of patients with reactive arthritis. lleocolonoscopy showed 
macroscopic abnormalities in 14 of 33 (HLA-B27 positive and negative) patients with 
idiopathic reactive arthritis [35]; a microscopic bowel wall inflammation was present in 
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31 of 33 patients. 
(c) Patients treated for morbid obesity by a jejunoileal bypass show, in 5-35% of the 
cases, an arthralgia or arthritis of limb and small peripheral joints [36,37]. The arthritis 
is transient and recurrent, and neither erosive nor deforming [38]. Rheumatoid factor 
usually is negative. Bacterial overgrowth of the blind loop and the small bowel is 
supposed to contribute to the joint inflammation [39,40]. Immune complexes containing 
antibodies against faecal flora antigens (Escherichia coli, Bacteroides fragilis) and 
complement components are found in serum of patients suffering from an acute attack 
of arthritis following intestinal bypass surgery [41]. Antimicrobial treatment results in 
improvement of the joint symptoms [37,39]. When the arthritis is otherwise untreatable, 
reconstruction of the continuity of the bowel leads to a rapid relief of joint inflammation 
symptoms [36,38]. 
(d) Ankylosing spondylitis (AS), a progressive stiffness of the lumbar vertebrate 
column, occurring predominantly in young male adults, is associated with the presence 
of HLA-B27 [42]. Investigators have shown a relationship with faecal carriage of 
Klebsiella in patients with active spondylitis [43], but these findings could not be 
confirmed by other groups [44]. Ebringer et al. [45] demonstrated an increased serum 
antibody titer against Klebsiella pneumoniae var oxytoca in patients with active 
spondylitis. Also, an increase in serum antibodies against a peptidoglycan moiety (D-
Ala-D-Ala) has been demonstrated in AS patients [46]. Several controversies exist 
regarding the mechanisms by which the immunological response to Klebsiella antigens 
may lead to disease, as has been lucidly reviewed by Keat [44]. Patients with AS and 
peripheral arthritis also show microscopic bowel wall inflammation upon ileocolonos-
copy. AS patients without peripheral arthritis showed less severe bowel wall inflamma-
tion [35,47,48]. AS patients also showed increased uptake of labeled ethylenediamine-
tetraacetic acid (EDTA) after oral ingestion, suggesting an increase in bowel wall 
permeability [49]. 
These clinical pictures demonstrate that, in some forms of sterile joint inflamma-
tion, a (bowel-related) microbial origin is strongly suspected. As has been stated, a 
microbial etiology has been suspected in RA for several decades. In 1922 the American 
surgeon Rea Smith reported on the beneficial effect of partial colectomies and ilea-
sigmoidostomies carried out in patients suffering from 'arthritis deformans' to remove 
'intestinal foci of infection' [50]. As of 1922 Crohn's disease had not yet been described 
as a separate disease entity, part of the above patients might in fact have been CD 
patients. This is supported by the observation that radiological abnormalities in the 
ileocecal region were seen in part of the patients described by Smith. 
An attractive feature of the hypothesis that the bacterial load originating from the 
bowel lumen is the initiating factor in RA is that not a single microorganism, but the 
microbial load as a whole, has to be responsible, taking into account that the microbial 
components must be presented in sufficient amounts [51]. A bacterial component 
common to all bacteria, i.e. the bacterial cell wall peptidoglycan, is a serious candidate 
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for causing joint inflammation symptoms. The permanent exposure of the immune 
system to these bowel derived antigens may account for chronicity of the disease. 
Clinical associations between arthritis and bowel inflammation or infection as shown 
above, together with findings in some animal models for arthritis (to be discussed in a 
following section), support this hypothesis. 
1.3 THE INDIGENOUS INTESTINAL FLORA AND RA 
With regard to the involvement of bacterial constituents from the intestinal 
contents in RA, several items need to be discussed; each one may contribute to the 
etiology of RA: 
(a) The bowel flora may be altered in RA. 
(b) In the bowel lumen of RA patients bacteria may disintegrate more than in healthy 
subjects (not experimentally supported). 
(c) The bowel wall of RA patients may be more permeable. 
(d) The immune system of RA patients may differ in its response to bowel-derived 
microbial constituents. 
(e) Joints of RA patients may be more prone to an immune response to microbial 
compound~ than joints of healthy subjects (HS). 
1.3.1 The intestinal flora of healthy individuals and RA patients 
The human indigenous bowel flora is characterized by the presence of very high 
numbers of bacteria in the colon and the terminal ileum. More than 30% of the faecal 
mass is bacteria with up to 2 x 1011 bacteria per gram faeces (wet weight), with > 99% 
of them being strictly anaerobic [52]. About 50% of the intestinal bacteria are Gram-
positive; of these bacteria, peptidoglycan is the major cell wall component making up 
30-70% of the cell wall [53]. Another hallmark of the human intestinal flora is the huge 
variety in bacterial genera and species. It is estimated that up to 400 anaerobic bacterial 
species may be present in the faecal flora of a single individual [52]. 
Major Gram-positive residents of the human intestinal flora are members of the 
genera Eubacterium, Bifidobacterium, Clostridium, Lactobacillus and Peptostreptococcus, 
each present in numbers exceeding 109 per gram faeces wet weight. The major Gram-
negative genera are Bacteroides and Fusobacterium [54]. The flora of the terminal ileum 
is less numerous and less heterogeneous than in the colon, with 1<f·5 to 106.3 bacteria/ml 
bowel contents [54]. The flora of the jejunum and the proximal ileum is even less 
numerous and is made up by. aerobes and a minority of anaerobes [54,55]. 
At birth, the bowel contents are sterile, but shortly afterwards E. coli and 
Streptococcus species are found and within 4-6 days nearly all full-term, vaginally-
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delivered infants are colonized with the anaerobes Bacteroides, Clostridium and 
Bifidobacterium. A major change in bowel flora occurs when the infant is weaned and 
when it gradually gets adjusted to 'adult' food. By the end of the second year the 
intestinal flora of a single individual reaches its definite composition [56] and remains 
stable for years [57]. No major changes in bowel flora composition occur with increasing 
age [58,59]. 
As has been demonstrated by van de Merwe et al., the composition of the faecal 
flora is under genetic influence: a study in twin pair children showed that the faecal flora 
of monozygotic twins are much more alike than those of dizygotic twins [60]. Patients 
with CD and their (a-symptomatic) children share an abnormal bowel flora, character-
ized by elevated numbers of Bacteroides species and the presence of Gram-positive 
coccoid rods [ 61]. 
The intestinal flora is important in the maintenance of colonization resistance [62], 
i.e. the presence of an indigenous flora impedes colonization by pathogens. The 
intestinal flora has a major influence on the structure and function of the gastrointestinal 
tract [63,64], plays an important role in shaping the developing immune system [64,65] 
and contributes to the metabolic activity of the digestive system [55,66]. 
Little is known about the composition of the bowel flora in RA patients, especially 
with regard to anaerobic bacteria. Olhagen and Mansson [15,67] demonstrated an 
increased number of C. perfringens in the faecal flora of RA patients. This observation 
was confirmed by Shinebaum et al. [68]. Differences in other bacterial species (E. coli, 
Klebsiella, Shigella, Salmonella, Yersinia, Pseudomonas, Proteus, Streptococcus faecalis), 
however, were not found. Total numbers of aerobes and anaerobes did not differ 
between RA and HS. Other research groups could not confirm the increased number 
of C. peifringens in the intestine of RA patients [69,70]. So far, investigators refrained 
from investigating the composition of the anaerobic intestinal flora, neglecting the 
majority of the intestinal bacteria. A recent report indicated that the jejunal flora may 
be altered in RA. With the help of jejunal aspirate cultures and glucose hydrogen and 
14C-glycocholate breath tests an abnormal jejunal flora was detected in 5 out of 17 RA 
patients [71]. Taken together, there is some experimental evidence that supports the 
hypothesis that in RA the bowel flora is altered. 
1.3.2 Structure and immunologic properties of peptidoglycan 
The bacterial cell wall owes its strength to peptidoglycan (PG). Basically, the PG 
structure is the same in Gram-positive and Gram-negative bacteria. It is a large 
biopolymer, made up of long amino sugar chains, cross-linked by oligopeptides (Fig. 1, 
left). The amino sugar chains consist of alternating N-acetylmuramic acid and N-acetyl-
D-glucosamine, coupled by 13-1,4 bonds. The carboxyl group of muramic acid is 
substituted by an oligopeptide which is directly, or via an interpeptide bridge, cross-
linked to adjacent peptide subunits [53,72]. This peptide moiety contains alternating L-
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and D-amino acids (Fig. 1, right). In Gram-positive bacteria, a thick, three-dimensional 
network of PG is constructed around the cell membrane. The composition of the amino 
sugar strand is almost identical in various bacteria, but the composition of the 
oligopeptide chains varies between species. These differences found between several 
genera and species have led to a taxonomic grouping [53]. 
I I I 0 
G G G G 
I \ G 0 0 0 \ 
M---=-M M- M-
I H NHAc H NHAc 
G G G G 
I CH3-~-H 
-M M- M---=-M co 
I I I I • Ala G G G G 
• I I I I D- Glu 
M- M___c:-M M- • DA_I_ D- Ala I I I I 
• • G G G G D- Ala DA 
I I I I • D-Giu M-=-M M-=-M • I I I I Ala 
• G G G G 
-M-G-M- G-I I I I 
Figure 1. (left) structure of a peptidoglycan monolayer: chains of amino sugars, linked by oligopeptides; 
(right) primary structure of a typical peptidoglycan fragment, made up by two amino sugar groups with 
oligopeptide side chains, linked by an interpeptide bridge. 
Abbreviations: Ac: acetyl; DA: D-diamino acid; G: N-acetylglucosamine; I: interpeptide bridge; M: N-
acetylmuramic acid. 
On the outer part of Gram-positive bacteria, the PG is covered by a polysaccharide 
layer covalently coupled to it, protecting the bacterial cell wall against enzymatic 
breakdown by lysozyme and digestion by host leukocytes [23,73]. In S. pyogenes, the 
polysaccharide part consists of polyrharnnose chains, with N-acetyl-glucosamine attached 
to it [73,74]. Of most other bacteria, especially the anaerobes, the composition of the 
polysaccharide layer is not known. Some PG constituents are unique for bacteria and are 
not found elsewhere, e.g muramic acid and D-alanine [53]. 
In Gram-negative bacteria the PG layer is less thick and less cross-linked by 
oligopeptide side chains than in Gram-positive microorganisms. PG accounts for less 
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than 10% of the Gram-negative cell wall [53] but may account for up to 70% of the cell 
wall in Gram-positive bacteria and is built up by 30-40 layers of amino sugar chains. 
PG has several potent immunological properties, as has been reviewed by Stewart-
Tun [75] and Heymer et al. [7]. Its biological activities have been reviewed by Dziarski 
[76]. PG activates complement by the alternate and classical pathways [77,78], and 
stimulates macrophages [76,79] leading to interleukin 1 (IL-l) production [80]. B-cells 
are polyclonally stimulated by PG [81-83]. The injection of PG in animals leads to the 
production of auto-antibodies e.g. rheumatoid factor, probably as a result of polyclonal 
stimulation of B lymphocytes [84 ]. The in vitro production of rheumatoid factor by PG-
stimulated lymphocytes has also been reported [85]. As suggested by Ginsburg [20], 
macrophages might fail to digest bacterial fragments after uptake; the release of partly 
degraded antigens by macrophages [86] may lead to a perpetual inflammation. Bare PG 
is quickly degraded in vivo [18,23], in contrast to PG covalently linked to polysaccharide 
which may persist in tissues for months [23,87,88]. The immunodominant part of PG with 
regard to antibody production is the peptide moiety; the amino sugar part is crucial for 
its adjuvant and arthropathic properties [72]. 
Tubercle bacilli ground in mineral oil potentiate the immune response to a protein 
component in water which has been subsequently emulsified in the mineral oil [89]. This 
adjuvant effect is exhibited by a fraction of the mycobacterial cell wall. However, 
mycobacteria can also be replaced by PG complexes of several other bacteria [90] or 
even muramyldipeptide [91,92]. 
In addition to these capacities PG can also induce arthritis in rats, as discussed 
in section 1.4. 
1.3.3 The uptake of bacterial antigens from the bowel lumen 
Translocation 
Intestinal bacteria are associated with the bowel wall: the mucus layer which covers 
the epithelial lining cells is colonized by bacteria, but bacteria probably do not adhere 
to the bowel wall [93]. This bowel wall-associated flora contains species which are also 
found in the bowel contents, but it is not clear whether or not the composition of this 
bowel-associated flora differs from that of the bowel contents. The passage of viable 
bacteria from the gastrointestinal tract through the epithelial mucosa to mesenterial 
lymph nodes is called translocation. As anaerobic bacteria seldomly translocate through 
an unaffected bowel wall [94] and (in the rabbit) indigenous anaerobic bacteria do not 
adhere in vitro to caecal epithelium [95], the uptake of whole anaerobic microorganisms 
through the bowel wall is much less than that of aerobic bacteria [94]. 
Regarding bacterial cell wall fragments ( CWF), which occur in the bowel contents 
in considerable quantities [96], the situation might be fully different. Small bacterial 
products liberated during bacterial growth and division [97-100] may more easily pass 
the bowel wall and spread to tissues. The presence of bacterial cell wall remnants in 
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mammalian tissues has been demonstrated elegantly by Sen and Kamovsky [101]. They 
detected muramic acid in liver, kidney and brain tissue of naive rats. The presence of 
anti-peptidoglycan antibodies in the serum of patients with RA also indicates exposure 
to bacterial antigens. 
Bowel wall penneability in RA 
Experimental results regarding bowel wall permeability in RA do not support the 
hypothesis that the bowel wall is more permeable in RA Reports in which low-
molecular weight test molecules, 51Cr-EDTA and polyethylene glycol (PEG) (M=400-
1000), are used, show that intestinal permeability probably is not increased in RA [102-
105]. In RA patients on non-steroid anti-inflammatory drugs (NSAID), an increased 
bowel wall permeability is seen. This can also be induced in healthy individuals and 
control patients by the administration of NSAID [ 49, 102,104]. On the other hand, neither 
macroscopic nor microscopic lesions were found during ileocolonoscopy of 20 RA 
patients using NSAID [47]. 
Bacterial cell wall fragments do occur in the bowel lumen, can be isolated from 
faeces and have a molecular weight of more than 2 x 105 D [96], which is substantially 
higher than of those of 51Cr-EDTA and PEG. During bacterial growth, PG fragments 
with a molecular weight ranging from about 10,000 to 300,000 D are secreted in the 
culture fluid [98]. Uptake of bacterial cell wall compounds through the bowel wall may 
take place by mechanisms such as pinocytosis, translocation and by M-cells of Peyer's 
patches [94]. Experimental evidence obtained by the use of low-molecular weight test 
molecules may be of limited value when the passage of macromolecular bacterial 
fragments through the bowel wall is studied. To cite Struthers et al.: 'If we are to 
demonstrate that passage of antigenic material through the intestinal wall is abnormal 
or increased in RA, molecules which resemble such material will have to be used for the 
tests' [105]. Regarding molecular weight, the findings of Fagiolo et aL are more relevant 
[106]: they used bovine beta-lactoglobulin (M=35,000) absorption as a permeability 
marker. In untreated RA patients an increased absorption was found, compared with 
inactive RA and controls; an increased permeability was observed in controls treated 
with acetylsalicylic acid. 
The experiments reported by Sartor et al. [107] give some additional information. 
They studied the uptake of labeled streptococcal CWF administered in the caecal lumen 
of rats. A small but detectable amount of CWF was demonstrated 48 hrs later in liver, 
spleen and mesenteric lymph nodes. The uptake of bacterial CWF increased more than 
tenfold when the colon wall was injured by the intraluminal injection of dilute acetic 
acid. Thus, in animal studies the uptake of bacterial cell wall fragments from the bowel 
lumen has been clearly established. 
Pritchard et aL [108] could not demonstrate the presence of muramic acid in 
rheumatoid synovial tissues and synovial fluid cells using a mass spectrometric 
procedure. Recently, on the other hand, muramic acid was shown to be present in septic 
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synovial fluid. This muramic acid could not be detected in synovial fluid with a low 
bacterial count [109]. The authors argued that their method may still be too insensitive 
to detect relevant amounts of bacterial remnants in synovial fluids. 
Serum antibodies to peptidoglycan 
Some investigators demonstrated elevated serum antibody levels to PG deter-
minants in RA patients [110,111]. Park et al., on the other hand, did not find an 
increased level of serum antibodies to a D-Ala-D-Ala peptidoglycan moiety in RA 
patients [46]. Ebringer et al. found increased serum antibodies against Proteus mirabilis 
in a group of RA patients [45,112]. 
Taken together, it can be concluded from this series of reports that the bowel wall 
is not necessarily abnormal in RA patients [113]. However, the bowel wall might be 
more permeate to bacterial compounds, as there is some evidence that the immune 
system of RA patients is more exposed to bacterial antigens. 
1.4 ANIMAL MODELS FOR JOINT INFLAMMATION 
It is difficult to study the etiological impact of the human intestinal flora in RA. 
Fortunately, some animal models for arthritis are available; four of them will be 
discussed here in more detail: 
(a) Antigen-induced arthritis; 
(b) Collagen-induced arthritis; 
(c) Adjuvant arthritis; 
(d) Streptococcal cell wall-induced arthritis. 
1.4.1 Antigen-induced arthritis 
The model of antigen-induced arthritis has been developed by Dumonde et al. 
[114]. In this model, animals are subcutaneously (s.c.) immunized with an antigen (e.g. 
bovine albumin) and boosted. When albumin is subsequently administered locally in a 
joint, an arthritis develops which subsides within several days. When the charge of the 
antigen is modified by methylation or amidation to increase its persistence in the joints, 
the joint inflammation becomes more chronic [115]. Antigen specific T-lymphocytes play 
a major role in the development of the arthritis: a joint inflammation can be established 
in naive mice when antigen specific T-lymphocytes are locally injected in the joint 
together with the antigen [116]. Even in nude mice an arthritis can be elicited by local 
injection of specific T-lymphocytes and antigen [116]. When the animal is challenged 
orally or intravenously (i.v.) after the waning of the acute arthritis a flare-up of the joint 
inflammation can be achieved [117-119]. 
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This animal model teaches us that: (a) to elicit a joint inflammation, the antigen 
has to be locally present; (b) antigen-specific T -lymphocytes play a major role in the 
pathogenesis of the disease; and (c) repeated exposure to the antigen leads to a flare-
up of the joint inflammation. Studies in this antigen-induced arthritis model gave us 
valuable insight in the mechanisms and pathogenesis of arthritis, but regarding the 
etiology of rheumatoid arthritis, its value is limited because of the artificial antigen. 
1.4.2 Collagen-induced arthritis 
An arthritis model with a more relevant antigen has been developed by Trentham 
et al. [120]. In this model, animals (mice, rats, rabbits, monkeys) are s.c. immunized with 
homologous or heterologous collagen type II in complete or incomplete Freund adjuvant. 
After 10-16 days these animals develop a self-limiting polyarthritis of paw joints which 
lasts for 4-8 weeks and may lead to joint ankylosis [120-122]. Early lesions are confined 
to the joint synovium. Erosions were rarely seen; rheumatoid factor could not be 
demonstrated. Both humoral and cellular mechanisms are involved in the development 
of the joint inflammation, as the disease can be transferred to naive recipients by 
collagen-specific antibodies as well as by the intravenous (i.v.) transfer of specific T-
lymphocytes [121]. Collagen-induced arthritis has several similarities with RA, but also 
many dissimilarities: collagen-induced arthritis lacks a spontaneous nature, is self-limiting 
without exacerbations and remissions, and the cellular and humoral immunity is directed 
against collagen type II only [123,124]. 
In man, immunity to cartilage collagen does not seem to play a major role in the 
pathogenesis of RA: a minority of RA patients show antibodies to native collagen type 
II, a phenomenon which may occur secondary to cartilage damage [125,126]. Cellular 
immunity against collagen has been demonstrated using peripheral blood lymphocytes 
but is regarded to be of minor importance [126]. 
1.4.3 Adjuvant-induced arthritis 
In this model, first described by Pearson [127,128], rats are immunized s.c. with 
complete Freund adjuvant (CFA), made of killed Mycobacterium tuberculosis ground in 
mineral oil. After a latent period of about 12 days, a majority of the rats develop a self-
limiting polyarthritis of limb joints, which lasts for several weeks and wanes in the 
majority of the animals, leaving deformed and stiff paws. Reimmunization with CF A 
induces a flare-up of the arthritis [129,130], a phenomenon ignored by some authors 
[131-133]. The joint inflammation is the most striking feature of a systemic disease. In 
this model, cellular immune mechanisms play a key role in the pathogenesis. The disease 
can be transferred to irradiated naive recipients by lymphocytes isolated from donor 
animals after CFA immunization [134,135]. Arthropathic T-celllines have been isolated 
from CF A-immunized rats by Holoshitz et al. [136]. They also isolated a T-cell clone 
15 
(A2b) by which the disease can be transferred to irradiated naive recipients [137] and 
another clone (A2c) which protects recipient rats from adjuvant-induced arthritis [138]. 
This A2c clone does not cause disease itself [138]. Rats can be vaccinated against 
adjuvant arthritis by pre-immunizing them with the 65 kD heat shock protein of M. 
tuberculosis [139], or with a synthetic nonapeptide identical to an immunodominant part 
of the 65 kD peptide [140]. It is supposed that antigenic mimicry between the 65 kD 
mycobacterium protein and the core protein of joint cartilage accounts for the disease 
[133, 139]. However, the spread of mycobacterial compounds to joint tissues shortly after 
injection of labeled CFA in the base of the tail has been demonstrated [141], and 
therefore also the local presence of mycobacterial compounds may play a role in the 
pathogenesis of adjuvant-induced arthritis. 
To induce polyarthritis, the M. tuberculosis in the CF A can be replaced by cell 
walls of other microorganisms, e.g. Streptococcus pyogenes, Nocardia [142,143] and 
Neisseria [144]. Not all bacteria are able to induce an arthritis when administered in 
mineral oil [142,143]. Adjuvant arthritis induced by CWF of bacteria from the indigenous 
human flora has not been reported. Recent (unpublished) studies from our group 
showed that Eubacterium aerofaciens CWF ground in incomplete Freund adjuvant (IF A) 
induced chronic persistent arthritis after s.c. inoculation in the tail base of Lewis rats. 
PG has been found to be the arthropathic cell wall compound [145]. The minimal 
PG structure with arthropathic properties when administered in IFA is the muramyldi-
peptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine [146-148]. The arthropathic 
activity of MDP depends on the mineral oil used and the amino acids coupled to the 
muramic acid: its stereoisomer N-acetylmuramyl-D-alanyl-D-isoglutamine does not 
induce arthritis [147]. 
This animal model has not only been used to study the arthropathic properties of 
isolated bacterial compounds, but also to investigate the influence of the intestinal flora 
upon an induced joint inflammation. Pearson et aL demonstrated that adjuvant arthritis 
can be induced in conventional as well as germfree (GF) rats [149]. Kohashi et al. found 
that GF F344 rats were highly susceptible to the induction of adjuvant arthritis, whereas 
specific pathogen-free (SPF) rats developed less severe arthritis and with a lower 
incidence [150]. GF rats which were colonized with E. coli or Bacteroides species showed 
less severe arthritis than SPF rats, whereas GF rats colonized with Propionibacterium 
acnes, Bifidobacterium or Lactobacillus species developed a more severe arthritis than 
GF rats. When GF rats were colonized with a mixture of E. coli and Lactobacillus 
species, a mild disease comparable to that in SPF rats was seen [151,152]. It is suggested 
that colonization by Gram-negative bacteria may suppress the disease via their lipopoly-
saccharide (LPS), whereas Gram-positive bacteria may enhance the disease, perhaps via 
their PG [152]. 
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1.4.4 Streptococcal cell wall-induced arthritis 
Bacterial cell wall-induced arthritis was originally described by Cromartie et a!. 
[87]. As we chose to adopt this model for our studies on the arthropathic properties of 
the human bowel flora, this model will be discussed in more detail. In this model a 
single dose of cell walls from Streptococcus pyogenes in aqueous solution is given intra-
peritoneally (i.p.) to rats of a susceptible strain. Within 24-48 hrs, the rats develop acute 
swelling of paw joints accompanied by general malaise, conjunctivitis and sometimes 
diarrhoea. The acute arthritis is most severe at about one week after cell wall injection. 
Subsequently it wanes and, after 2-3 weeks, it relapses as a chronic polyarthritis of the 
limbs. This chronic joint inflammation waxes and wanes, and may last for several 
months, leading to joint deformation, stiffness and ankylosis. Axial, knee and smaller 
limb joints are less frequently involved. The arthritis, especially the chronic phase, is 
clearly dose-dependent [87]. 
The immune mechanisms which occur during the acute and chronic phase of the 
joint inflammation differ profoundly. The acute phase is complement-dependent: 
treatment with cobra venom factor 3 days before bacterial cell wall administration 
reduces the severity of the acute joint inflammation, whereas the chronic phase remains 
unaffected [153]. The acute systemic disease may lead to death within 1-2 days after cell 
wall injection [87,154]. In Streptococcus group B injected rats a severe decrease in 
platelet numbers and plasma fibrinogen levels has been found [155], although this is 
insufficient to explain the death of the rats. The humoral response which follows cell 
wall injection is less well correlated with the severity of joint inflammation [156,157]. 
Nude (athymic) Lewis rats show an acute paw inflammation after i.p. CWF administra-
tion, but do not develop chronic joint disease [88,158]. When nude rats are supplement-
ed with lymphoid cells of euthymic littermates, they develop an acute as well as a 
chronic arthritis after cell wall injection [158]. Therefore it was concluded that T-
lymphocytes are essential for the development of a chronic joint inflammation, whereas 
the acute phase is T-cell independent [88,158]. Additional support for this hypothesis 
was given by the finding that cyclosporin A inhibits the chronic phase of the arthritis 
[159]. A recent report on the transfer of streptococcal cell wall (SCW) arthritis to naive, 
irradiated rats by SCW-specific T-cell lines isolated from arthritic animals again 
confirmed the central role of the T-lymphocyte in bacterial cell wall-induced chronic 
arthritis [160]. 
There is a great difference in arthritis susceptibility among rat strains and sex: 
Sprague Dawley and Lewis rats are highly susceptible, whereas Buffalo and F344 rats 
demonstrate a self-limiting acute arthritis without a chronic phase upon i.p. injection of 
SCW [161,162]. No differences in tissue distribution of cell walls were found between 
susceptible and resistant rat strains [163,164]. The differences in susceptibility are 
probably not major histocompatibility complex (MHC)-related, as Lewis and F344 rats 
share the same MHC [165]. Female rats appeared to be more sensitive than male rats 
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[162]. Castration or oestrogen administration increased the susceptibility of male rats to 
chronic arthritis [166]. It is suggested that SCW-induced suppression ofT-cell function 
in the F344 rat is responsible for its umesponsiveness [167]. Recent reports show that 
Lewis rats have a central nervous system defect in the biosynthesis of corticotropin-
releasing hormone, whereas (arthritis resistant) F344 rats have an intact hypothalarnic-
pituary-adrenal axis activation upon exposure to bacterial cell walls and IL-1 [168,169]. 
A recent study in RA patients reported disturbances in circadian cortisol patterns, 
especially in patients with high inflammatory activity [170]. 
Mice do not develop chronic joint inflammation after i.p., i.v. or intra-articular 
(i.a.) injection of sew [171], but show a pancarditis after a single i.p. injection of sew 
[172]. 
Chronicity of the joint inflammation 
Chronicity is an important feature of SCW-induced arthritis. Insight into 
mechanisms which contribute to chronicity in the rat model might help to understand 
the chronic nature of human RA. Several factors play a role in chronicity: 
(a) The molecular size of the injected sew influence the outcome of cell wall 
administration: sew smaller than 5 X 105 D do not induce arthritis whereas fragments 
up to 5 x 106 D do induce an acute, self-limiting arthritis. Fragments between 5 x 106 D 
and 500 x 106 D give rise to a joint inflammation with both an acute and a chronic 
phase. CWF larger than 500 x 106 D produce chronic arthritis without an acute phase 
[173]. 
(b) The outcome of the joint inflammation also depends on the injection route: neither 
the i.v. nor the i.a. route leads to chronic arthritis [73] (table 1), in contrast to the i.p. 
injection. 
(c) It is essential that the peptidoglycan-polysaccharide (PG-PS) complex is intact: the 
i.p. injection of purified streptococcal PG leads to an acute, self-limiting arthritis without 
chronicity [87]; the i.p. administration of the purified polysaccharide (PS) component 
induces transient paw edema [73]. It has been supposed that an increase in synovial 
vascular permeability induced by PS makes joints more accessible for cell walls, 
favouring the chronicity of the subsequent arthritis [73]. However, pretreatment of rats 
before the i.p. administration of sew to block mast cell degranulation abrogated the 
acute paw edema but neither prevented sew deposition in the joints nor the 
development of chronic arthritis [174]. This argues against the supposed mechanism for 
the role of cell wall PS in the spread of bacterial antigens. 
PG without coupled PS was found to be more sensitive to lysozyme digestion than 
native PG-PS complexes [175]. It is supposed that the PS attached to PG protects it 
against in vivo degradation by lysozyme, thus contributing to chronicity. sew that were 
acetylated to render them more sensitive to lysozyme were found less arthropathic than 
native sew after i.p. injection [176]. 
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Table 1. Joint inflammation induced by bacterial cell wall compounds administered via different routes 
Injection route PG-PS* PG PS 
intraperitoneal chronic acute oedema 
intravenous acute acute oedema 
intra-articular acute acute oedema 
• PG-PS: peptidoglycan-polysaccharide complex. 
An i.v. injection of mutanolysin ( endo-N-acetylmuraminidase) after an i.p. injection 
of an arthropathic dose of sew in rats abrogates the development of chronic joint 
inflammation [177]. This beneficial effect of mutanolysin possibly is due to a decrease 
in sew size, leading to an inability of these digested cell walls to activate complement 
[178]. 
The presence of rhamnose in bacterial cell walls is thought to be related to 
chronicity of the joint inflammation [179,180] but its mechanism is still unclear. 
Rhamnose might make the bacterial cell wall more resistant to lysozyme digestion, thus 
contributing to persistence of bacterial cell walls in tissues. According to Lehman et al. 
[180], a bacterial cell wall has to be lysozyme-resistant and to contain rhamnose to 
induce a chronic arthritis after i.p. injection. 
The persistence of bacterial CWF in tissues is assumed to contribute greatly to 
the chronic nature of the resulting joint inflammation. An i.p. injection of CWF results 
in a distribution of cell walls in other organs and tissues: cell wall antigens are found in 
the joints (synovium as well as subchondral bone), liver, spleen and lymph nodes, 
especially in tissue macrophages [87,88,181,182]. Cell walls are cleared from tissues over 
the course of weeks to months, but were found to persist for up to three months in joint 
tissue macrophages after a single i.p. injection [87]. It is supposed that release of CWF 
from the liver, subchondral bone or other organs leads to flare-ups and so contributes 
to chronicity of the joint inflammation [88]. Evidence is accumulating that part of the 
synovial lining cells (the type A cells) are in fact bone marrow-derived macrophages 
[183]. These lining cells may therefore be responsible for transport of bacterial 
compounds from bone marrow deposits to the synovium. La. injected bacterial cell walls 
have been shown to persist in macrophages for at least several weeks [184]. The 
presence of muramic acid in joint tissues of rats, i.p. injected with streptococcal CWF, 
has been demonstrated by Fox et al. by gas-liquid chromatography-mass spectrometry 
[185]. They did not find muramic acid in naive rat tissue, in contrast to Sen and 
Karnovsky [101]. 
The ability of bacterial cell walls to persist in tissues is also illustrated by the 
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development of liver granulomas in rats i.p. injected with sew [162]. These granulomas 
were not found when cell walls of Lactobacillus casei were used [186]. 
Several experimental procedures have been shown to be effective in the 
reactivation of a joint inflammation. I.v. injection of homologous and heterologous cell 
wall polymers, e.g. PG or LPS, leads to reactivation of joint inflammation previously 
induced by the i.a. injection of sew [187,188]. The repeated i.a. injection of IL-l in 
joints previously injured by an i.a. sew injection results in a series of flares, which leads 
to a more severe histopathological change than seen after a repeated IL-l injection in 
naive joints [189]. Joints which are already damaged are more susceptible to a 
subsequent joint inflammation [189, 190]. Repeated i.v. injections of small doses of SCW 
lead to a joint inflammation with increasing severity [191 ]. These experiments made 
clear that, once a joint inflammation is established, it can easily be reactivated by a cell 
wall dose too low to induce joint inflammation in a naive animal. A series of 
reactivations by minimal amounts of bacterial agents may lead to chronicity. In the SCW 
model, a continuous release of bacterial fragments from tissue depots probably is 
responsible for chronicity. In RA, bowel-derived bacterial antigens may play such a role 
in maintenance of chronicity. 
The impact of the indigenous bowel flora on joint inflammation has also been 
demonstrated using the SCW model. As already stated, F344 rats are known to be 
resistant to induction of chronic arthritis by i.p. injection of SCW [162]. However, GF 
F344 rats are susceptible to induction of chronic arthritis, and colonization of GF F344 
rats by a conventional rat flora leads to an increasing resistance to induction of chronic 
arthritis [192]. 
Recently it has been reported that vaccination against SCW-induced arthritis can 
be achieved by pre-immunization with the 65 kD Mycobacterium protein. This 
vaccination reduces the severity of the acute phase of the joint inflammation and almost 
completely abrogates the chronic phase of the arthritis [193]. The mechanism of this 
vaccination probably is the induction of suppression of the SCW-specific T-cell response. 
Histological analysis of SCW-induced arthritis 
Paw joint sections of rats with an acute SCW-induced arthritis show peri-articular 
tissue oedema and infiltration of synovial tissue, tendon sheaths and peri-articular tissue, 
with predominantly polymorphonuclear cells (PMN). Synovial lining cells are swollen 
and inflammatory cells around synovial vessels can be seen. In the joint cavity, 
inflammatory cells, mainly PMN, can be found. Cartilage and bone usually are 
unaffected [87,88,181]. 
The chronic phase of the arthritis is characterized by a shift in inflammatory cells 
from PMN to lymphocytes. In the synovium the lymphocytes predominate, but PMN, 
synoviocytes [194] and macrophages are also present [87,88,181]. The synovial lining 
shows hyperplasia with an increased MHC class II molecule expression on lining cells 
[195]. Synovial vascular proliferation is also seen. In the infiltrated synovium, CD4 + T-
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lymphocytes dominate, whereas CD8+ T-cells occur at a much lower frequency [88]. 
The inflamed synovium may enter the joint space and even overlay the cartilage [87,88], 
a pattern similar to pannus formation in RA. Cartilage and bone are affected in chronic 
arthritis: marginal cartilage erosions occur adjacent to inflamed synovium. Usually the 
underlying bone is also damaged [87,88,181]. At multiple locations, a periosteal 
apposition of new bone tissue can be seen. Destruction of cartilage and underlying bone 
tissue followed by connective tissue replacement may even lead to fibrous ankylosis of 
the joint [87,88]. The paw inflammation is not confined to the synovial lining, cartilage 
and bone; the tendon sheath lining is also affected. PMN and lymphocytes are seen in 
the tendon sheath, with swelling of the lining cells and PMN in the space between 
tendon and sheath [87,88,181]. 
The histopathological pattern seen in inflamed joints of SCW-injected rats has 
many features in common with RA: synovitis with infiltration by lymphocytes and PMN, 
and marginal cartilage erosions with bone destruction and apposition of new bone and 
pannus formation. However, the strong synovial lining cell proliferation found in RA is 
less expressed in this animal model. Also, the lymphoid follicle-like noduli which are 
characteristic of RA have not been found in the rat model. Some other effects seen in 
streptococcal CWF injected rats are also reminiscent of RA. The protracted anaemia 
seen after i.p. CWF injection (PG or PS alone is not effective) is also observed in RA; 
it is related to a decreased erythrocyte survival time, a phenomenon also observed in 
adjuvant arthritis and RA [196]. An unresponsiveness to skin testing with streptococcal 
CWF and an in vitro unresponsiveness of lymph node cells to phytohaemagglutinin 
stimulation is seen in rats 3-30 days after an arthropathic cell wall dose [197]. The 
depressed T-cell function found in arthritic rats was associated in vitro to the presence 
of macrophages [198]. This phenomenon has similarities to the anergy found in patients 
with active RA [199]. 
Spontaneous arthritis is not only seen in humans but has also been described in 
rats and mice: Trentham et aL reported on a group of 430 naive female Sprague Dawley 
rats in which two rats with spontaneous arthritis were seen. Joint inflammation with a 
higher incidence ( 6%) was observed in total lymphoid irradiated rats. The severity and 
pattern of joint inflammation were similar to those observed in rats with collagen or 
adjuvant arthritis [200]. 
Arthritis is seen not only after Streptococcus pyogenes cell wall injection. CWF of 
Lactobacillus casei [186], Lactobacillus plantarum [180], Streptococcus group B, C, H, and 
Streptococcus mitis [87], Streptococcus faecium [179] and Peptostreptococcus productus 
[179] also have arthropathic properties. In contrast, CWF from Staphylococcus aureus 
[87], Propionibacterium acnes and Methanobacterium formicium [179] failed to elicit joint 
inflammation symptoms after a single i.p. injection. 
We employed a modification of the SCW model for our studies on the role of 
anaerobic intestinal bacteria in the etiology of chronic arthritis in man. The two models 
which use bacterial compounds (adjuvant arthritis and the sew model) have advantages 
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as well as disadvantages. In the SCW model the joint inflammation is far more chronic 
[87,181] than in the adjuvant model [127-130]. This aspect of the adjuvant model 
disagrees with the chronic nature of RA and the hypothesis that a continuous influx of 
bacterial antigens from the bowel maintains chronic joint inflammation. 
Arthropathic properties of intestinal flora bacteria have, as yet, not been 
investigated in either model. Regarding the bacterial cell wall model, little information 
is available. Lehman et al. reported on the arthropathic properties of Lactobacillus 
species [164,180], while Stimpson et al. chose S. faecium, P. productus, P. acnes and M 
formicium as representatives of the human indigenous flora [179]. These microorganisms, 
however, do not represent the group of major bowel residents [52,57-59]. Furthermore, 
the bacteria to which the bowel mucosa is exposed far outnumber the bacteria which are 
found on the skin [201], the mucosa of the mouth [202] or the genital tract [203]. The 
digestive tract is therefore most likely the primary source of exogenous bacterial antigens 
to which the immune system is exposed. 
Taken together, the absence of a specific causative microorganism in RA, the 
relation between arthritis and bowel inflammation or infection, the inflammatory 
properties of bacterial cell wall compounds, and the outcome of animal studies, plead 
for further investigations of the arthritis-inducing properties of bacterial cell compounds 
originating from the human indigenous intestinal flora. 
1.5 INTRODUCTION TO THE EXPERIMENTAL WORK 
We started by investigating the arthritis-inducing properties of cell walls from four 
Gram-positive human anaerobic intestinal flora bacteria which are associated with CD. 
Three out of the four strains tested were isolated from the faecal flora of a patient with 
CD. Patients with CD were found to have antibodies to these bacterial strains more 
often, and with a higher titer than healthy subjects [204]. A serological assay for the 
diagnosis of CD, using four intestinal anaerobic coccoid rods, is being applied in our 
laboratory [204,205]. As these intestinal bacteria may not only be relevant for the 
gastrointestinal symptoms of CD [206,207] but also for the joint disease complicating 
CD, CWF from these strains were tested in the animal model described above. The 
procedure and the results are presented in Chapter 2. 
Chapter 3 represents a more detailed study of the arthropathic properties of 
intestinal flora bacteria and describes the arthritis-inducing capacities of nine strains 
from four representative, Gram-positive, anaerobic bacterial genera from the human 
intestinal flora. The impact of cell wall rhamnose and cell wall resistance to lysozyme 
on arthropathic properties is also investigated. 
In Chapter 4, several Eubacterium species are investigated to clarify the wide range 
of arthropathic properties found in Chapter 3. A profound variation was observed 
between the tested Eubacterium strains. Using a set of cell walls from the same bacterial 
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genus, the hypothesis is tested that cell wall rhamnose contributes to chronicity of joint 
inflammation; also the role of lysozyme sensitivity in the induction of chronic arthritis 
is discussed. 
In Chapter 5 the joint inflammation induced by i.p. E. aerofaciens CWF administra-
tion is studied at various time intervals and described in more detail. Decalcified joint 
tissue embedded in paraffin is used to study the histopathological changes. The findings 
are compared with descriptions of the streptococcal and Lactobacillus cell wall-induced 
arthritis as well as with human RA. 
The composition and arthropathic properties of the intestinal flora in RA are 
investigated in chapter 6. The faecal flora of 10 RA patients is compared with that of 
10 healthy subjects with special attention to Eubacterium and Bifidobacterium species. 
Cell wall preparations from E. aerofaciens strains isolated from RA patients, as well as 
healthy subjects, are tested in the bacterial cell wall model. 
In the final chapter, I shall discuss the experimental findings and relate these to 
the hypothesis that the intestinal flora plays a role in the induction and maintenance of 
chronic joint inflammation in man. 
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CHAPTER2 
INDUCTION OF CHRONIC ARTHRITIS IN RATS BY CELL WALL FRAGMENTS 
OF ANAEROBIC COCCOID RODS ISOLATED FROM THE FAECAL FLORA 
OF PATIENTS WITH CROHN'S DISEASE 
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SUMMARY 
Crohn's disease (CD) and ulcerative colitis are accompanied by seronegative 
arthritis in about one fifth of the cases. In the present study, cell wall fragments (CWF) 
from major residents such as Eubacterium, Coprococcus and Peptostreptococcus species, 
isolated from the faecal flora of patients with CD, were tested for properties to induce 
chronic arthritis in Lewis rats. CWF from Eubacterium contortum strains Me44 and Me47 
were found to induce chronic arthritis; Peptostreptococcus productus strain C18 CWF 
induced acute self-limiting arthritis. Coprococcus comes strain Me46 cell walls, on the 
other hand, were found to be lethal to the majority of rats inoculated, whereas those 
which survived did not develop acute or chronic arthritis. These results indicate that 
intraperitoneal (i.p.) injection of a single dose of CWF from bacteria that are major 
residents of the human anaerobic faecal flora can induce chronic inflammatory joint 
disease in the rat. 
INTRODUCTION 
Both CD and ulcerative colitis are often (14-39%) accompanied by inflammation 
of one or more large peripheral joints or the spine [1 ]. The arthritis usually parallels the 
activity of intestinal disease. The pathogenesis is not known but the higher frequency of 
arthritis in colonic CD as compared to ileal CD [1,2] suggests a role of intestinal 
bacteria, known to occur in much higher numbers in the colon than in the ileum. Fifteen 
per cent of patients with intestinal bypass surgery for morbid obesity develop arthritis, 
supposed to be due to immune complexes formed as a result of bacterial overgrowth of 
the surgical blind loop [3,4]. Enteritis caused by Shigella flexneri., Salmonella, Yersinia 
enterocolitica and Campylobacter may be complicated by a sterile arthritis, particularly 
in patients with the HLA-B27 antigen [5], whereas enteritis due to Shigella sonnei is not 
accompanied by arthritis [6], indicating that small differences between bacteria may also 
affect the chance on arthritis. 
The bowel is a reservoir of foreign antigens to which the host is permanently 
exposed. Bacterial counts in colonic contents exceed 1011 per gram of faeces, more than 
99% of which are obligate anaerobic bacteria. Previous studies showed that the faecal 
flora of patients with CD contained more Gram-positive obligate anaerobic coccoid rods 
than the flora of healthy subjects [7,8]. Sera from CD patients agglutinated 4 strains of 
coccoid rods, belonging to E. contortum (strains Me44 and Me47), P. productus (strain 
C18) and C. comes (strain Me46) species, more frequently and stronger than sera from 
healthy subjects, patients with ulcerative colitis or other diseases [9-11 ]. These data 
indicate that the immune system reacts to antigens from obligately anaerobic bacteria 
from the intestinal lumen. 
An etiological role in rheumatoid arthritis of intestinal bacteria has been proposed 
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by Bennett [12], supposing that peptidoglycan, the major constituent of Gram-positive 
bacteria, pass the gut-blood barrier and stimulate the immune system. The purpose of 
the present study was to investigate whether CWF from major residents of the anaerobic 
faecal flora of patients with CD could induce arthritis in rats. 
MATERIALS AND METHODS 
Arthritis was induced in rats by i.p. injection of bacterial CWF as described by 
Cromartie et al. [13] for streptococcal cell walls. 
Animals 
Groups of five rats were injected i.p. with CWF of Streptococcus pyogenes, the 
coccoid anaerobes (see below) or with sterile phosphate-buffered saline (PBS) as a 
control. The cell wall dose was adjusted to 33 or 50 f.Lg of muramic acid per g of body 
weight for S. pyogenes and to 25 or 50 f.Lg for the coccoid anaerobes. The animals that 
received the low cell wall dose of S. pyogenes were observed during 50 days, the other 
during 60 days. Diameters of wrists and ankles were measured with a vernier caliper 5 
x in weeks 1 and 2, 3 x in weeks 3 and 4, 2 x in weeks 5 and 6, and once in weeks 7-9. 
Female Lewis rats (Olac Ltd, Bicester, UK), weighing 150-193 g were used. 
Bacteria 
Three strains of anaerobic coccoid rods with code numbers Me44, Me47 (E. 
contortum) and Me46 (C. comes) were isolated from patients with CD as described 
previously [8]. P. productus strain C18 was obtained from Dr W.E.C. Moore (Anaerobe 
Laboratory, Virginia Polytechnic Institute and State University, Blacksburg, USA). The 
strains were cultured in Proteose-Pepton broth (20 g Proteose-Peptone (Oxoid), 1 g 
glucose; 3 g NaCl; 3 g K2HP04.3Hp; 0.5 g KH2P04; 0.5 g MgS04.7Hp; 0.5 g 
cysteine-HCl per liter, pH 7.2), or in Schaedler broth (Oxoid). Bacteria were grown in 
a 20-liter vessel overnight under anaerobic conditions at 37°C after inoculation with a 
log phase culture. S. pyogenes T3 was obtained from the Bacteriological Laboratory, 
Academic Hospital Rotterdam Dijkzigt, and cultured overnight at 37°C in Todd Hewitt 
broth (Oxoid). 
Preparation of cell wall fragments 
CWF were prepared according to Cromartie et al. [13]. In short: cells were 
harvested, washed, disrupted with glass beads in a Braun shaker (Melsungen, FRG) and, 
subsequently, collected by centrifugation, washed, lyophilized and treated with 
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ribonuclease and trypsin, washed and lyophilized again. The crude cell walls were 
resuspended in PBS and sonicated (MSE, Crawley, UK) at maximal power during 75 
min. The sonicated cell walls were passed through a 0.45 J.Lm filter (Schleicher and 
Schull, FRG) and tested for sterility on sheep blood agar plates. Muramic acid and 
rhamnose were determined as described by Hadzija [14] and Dische and Shettles [15], 
respectively. 
Statistical analysis 
The differences between the sums of all 4 paw diameters of each individual rat on 
day 0 and on each observation day were calculated; the median difference of rats 
injected with CWF from the same bacterial strain were, subsequently, calculated for each 
observation day; these median values for each observation day for the group of rats 
injected with cell walls from a particular bacterial strain were compared with the median 
values obtained in rats injected with CWF from another bacterial strain using the 
Wilcoxon signed rank test. 
Histology 
After the observation period, rats were sacrificed by cardiac puncture bleeding 
under ether anaesthesia. Skinned ankle joints were fixed in 1:10 (v/v) diluted buffered 
formaldehyde 36% solution, decalcified in 5% (v/v) formic acid during 5 days and 
subsequently embedded in paraffin. Sections were stained with hematoxylin and eosin. 
RESULTS 
CWF of S. pyogenes 
Rats, inoculated i.p. with a single dose of CWF from S. pyogenes gradually 
developed a polyarthritis of the paws, the arthritis being more severe when the high dose 
was used (Table I and Fig. 1). No arthritis was seen in rats inoculated with saline. These 
data are in line with results of Cromartie et al. [13] and confirm the usefulness of the 
bacterial cell wall model in our hands. 
CWF fragments of anaerobic coccoid rods 
Varying degrees of arthritis were observed after i.p. inoculation of rats with 
different species and strains of the anaerobic coccoid rods (Table I and Fig. 1). In 
general, more severe acute and chronic arthritis was seen with higher cell wall doses. 
Cell walls from E. contortum strain Me44 induced more severe arthritis than those 
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Figure 1. Inflammation induced in rat paws by the i.p. injection of bacterial CWF. Rats were inoculated on 
day 0 with a cell wall dose of 50 }Lg muramic acid per g body weight. 
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Table I. Effect of i.p. injection of CWF from anaerobic Gram-positive coccoid rods from tbe faecal flora 
from patients with CD as compared with those from S. pyogenes 
CWF from bacterium 
(strain) 
S.pyogenes 
E. contortum (Me44) 
E. contortum (Me47) 
C. comes (Me46) 
P. productus (C18) 
Control 
Arthritis in surviving rats1 
50 J.Lg muramic acid/g 
body weight 
5/5 
5/4 
5/4 
5/2 
5/5 
5/5 
Acute 
+/++ 
+++ 
+/++ 
+/++ 
Chronic 
++/+++ 
+++ 
+ 
1
: arthritis in surviving rats, + mild, + + moderate, + + + severe. 
2
: number of rats injected intraperitoneally/number of surviving rats. 
25 J.Lg muramic acid/g 
body weight 
N/S Acute Chronic 
5/5 + + 
5/5 ++ ++ 
5/5 + +I-
5/1 
5/5 + 
from S. pyogenes (p=0.0006), as indicated by the increase of sum paw diameters during 
the whole observation period. The potency of cell walls to induce chronic arthritis 
seemed to parallel their rhamnose contents but not their muramic acid contents (Table 
II). 
Table II. Chemical composition of CWF preparations (% of dry weight) 
Source of CWF Muramic acid Rhamnose 
S.pyogenes 11.6 20.4 
E. contortum (Me44) 20.1 72.0 
E. contortum (Me47) 14.7 40.1 
C. comes (Me46) 9.3 0.8 
P. productus (C18) 16.4 1.2 
39 
Histology 
Arthritic joints of rats were histologically examined after the observation period. 
Hind paw joints of rats inoculated with cell walls of S. pyogenes showed extensive 
infiltration of synovial and periarticular tissues, including tendon sheets, with poly-
morphonuclear and some mononuclear cells (Fig. 2a). Joint cavities also contained 
polymorphonuclear granulocytes and mononuclear cells. Synovial lining cells were 
swollen or destructed, and marginal erosions of cartilage and new bone formation were 
seen. These results are in line with those from Cromartie et al. [13]. Histology of rats 
inoculated with low dose of E. contortum strain Me44 cell walls revealed swollen synovial 
lining cells and slight cell destruction. Synovial tissue infiltration with mononuclear and 
some polymorphonuclear cells, marginal cartilage erosions and prominent periostal 
apposition of new bone were also seen (Fig. 2b ). 
Figure 2. Histological appearance of joint inflammation induced by bacterial CWF: (a) section through a hind 
paw joint of a rat, sacrificed 43 days after inoculation with low dose of streptococcal CWF. A dense synovial 
tissue infiltration, synovial lining cell destruction and marginal cartilage erosions are present; magnification: 
134 x. (b) section through a hind paw joint of a rat, sacrificed 60 days after i.p. injection of E. contortum 
strain Me44 CWF. Infiltration of synovial tissue and marginal cartilage erosions can be seen; magnification: 
108 X. 
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DISCUSSION 
Inability of the host to degrade peptidoglycan-polysaccharide complexes of S. 
pyogenes is supposed to be important for the induction of arthritis or chronic granuloma-
tous reactions in the bowel wall [16-18]. Our results with P. productus, inducing 
self-limiting acute arthritis, are in line with recent results by Stimpson et aL [19], who 
also found that CWF of Streptococcus faecium, a facultatively anaerobic bacterium that 
may occur in small numbers in the human faecal flora, induce chronic arthritis in the 
rat. The present study shows that single i.p. injection of CWF from Eubacterium species, 
being major residents of the anaerobic faecal flora of both healthy subjects and patients 
with CD, can produce severe acute and chronic arthritis in the rat. 
Rhamnose contents of CWF from E. contortum strain Me44 and P. productus strain 
C18 were found to be 72.0 and 1.2%, respectively. The rhamnose contents of E. 
contortum strain Me44 is extremely high but was found on repeated occasions. The 
rhamnose contents of P. productus strain C18, on the other hand, was low when 
compared with data from Stimpson et aL [19]. As this percentage was found repeatedly, 
we assume that different culture media and techniques as well as different isolation 
methods may be responsible for this discrepancy. The potency of cell walls to induce 
chronic arthritis appeared to parallel their rhamnose contents, a phenomenon observed 
previously by Stimpson et aL [19]. The small number of bacterial strains investigated, 
however, does not allow definite conclusions at present. 
Peptidoglycan-polysaccharide complexes have been detected in synovial and 
periarticular tissues [20]. The polysaccharide portions of these complexes are probably 
essential for the induction of chronic arthritis [21]. Biochemical differences between 
polysaccharide chains of the complexes obtained from different bacterial strains may thus 
be responsible for variations in capacity of individual strains to induce chronic arthritis. 
Bacteria of the indigenous human faecal flora are in close contact with the 
absorbing surfaces of the intestines. Bacterial CWF may be continuously released in the 
intestinal lumen; if these fragments are absorbed, they could induce arthritis in 
susceptible hosts. Genetically determined individual variation of the indigenous 
anaerobic faecal flora [22], in combination with individual variation of host susceptibility 
[23] may be expected to lead to highly variable expression of arthritis caused by bacterial 
CWF from the intestinal lumen. 
Sartor et aL [17] recently showed that, in addition to arthritogenic properties, CWF 
from S. pyogenes could induce granulomatous enterocolitis after injection in the bowel 
wall. The present study indicates that the arthritogenic properties of E. contortum strain 
Me44, isolated previously from the resident anaerobic faecal flora from patients with CD 
[7], are stronger than those of S. pyogenes. This finding warrants further study on the 
possible release of peptidoglycan-polysaccharide complexes in the bowel lumen and the 
circumstances affecting the release and absorption of bacterial CWF in vivo. Absorption 
of antigens of the anaerobic coccoid rods is likely on the basis of the high incidence of 
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specific antibodies to these bacteria in CD [10, 11]. In line with the results of Sartor et 
aL [17], absorption of peptidoglycan-polysaccharide complexes from E. contortum strain 
Me44 out of the intestinal lumen could be expected to result in granulomatous intestinal 
inflammatory reaction. 
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SUMMARY 
To investigate the involvement of human intestinal flora in joint inflammation, cell 
wall fragments (CWF) of nine anaerobic Gram-positive bacteria of the human faecal 
flora were prepared and tested for arthropathic properties in the rat. A single 
intraperitoneal (i.p.) injection of CWF from Eubacterium aerofaciens or Bifidobacterium 
species induced persistent chronic arthritis, in contrast to those from Eubacterium rectale, 
Clostridium species and Lactobacillus leichmanii. The results show that CWF of major 
residents from the human faecal flora can induce chronic arthritis in the rat and support 
the hypothesis that the normal human intestinal flora plays a role in the induction of 
arthritis in man. 
INTRODUCTION 
The etiology of rheumatoid arthritis (RA) and other forms of sterile arthritis still 
remains obscure. Bennett [1] postulated that bacterial products or fragments, originating 
from the bowel contents, may pass the blood-gut barrier, stimulate the immune system 
and induce RA. Clinical observations show a relationship between joint inflammation 
and bowel disease, such as arthritis complicating Crohn's disease (CD) and ulcerative 
colitis [2], reactive arthritis following bowel infection [3] and jejuno-ileo bypass arthritis 
which may complicate surgical treatment of obesity [4]. 
The human bowel flora is characterised by the presence of up to 1011 obligate 
anaerobic bacteria per g of faeces [5]. Therefore, the gut associated lymphoid tissue is 
in close contact with a huge amount of antigens mainly from anaerobic bacteria during 
a lifelong period. Some of these bacterial antigens might pass the bowel wall, particularly 
if the permeability of the bowel wall is increased by intestinal inflammation [6] and give 
rise to inflammation symptoms at distant locations such as arthritis, a possible 
mechanism occurring in 15% of patients with Crohn's disease [2]. 
Arthritis induction in rats by peptidoglycan-polysaccharide complexes from cell 
walls of Streptococcus pyogenes has been extensively described by tbe group of Cromartie 
et al. [7,8]. We adopted this model for our studies on tbe induction of arthritis by 
intestinal flora bacteria. In a first report [9], we investigated in the animal model the 
arthritogenic properties of CWF from four anaerobic Gram-positive intestinal bacteria, 
isolated from a patient with CD. Serum antibodies to these strains are frequently found 
in patients with CD [10], indicating that the immune system reacts to these intestinal 
bacteria. CWF of Eubaderium contortum strain Me44 could induce chronic polyarthritis 
in rats. According to Moore and Holdeman [5], however, this species represents only a 
minority of the variety of species by which the human intestinal flora is characterised. 
The limited number of strains tested in our first report does not permit us to draw firm 
conclusions about the arthropathic properties of intestinal bacteria in general. Other 
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literature reports about arthritis inducing properties of residential flora bacteria are 
confined to Lactobacillus species [11, 12], Peptostreptococcus productus [13] and a few 
minor indigenous flora bacteria [13]. Thus, the hypothesis that the anaerobic intestinal 
flora is involved in arthritis in man has received limited experimental support in this 
animal model. We tested CWF of nine species of Gram-positive bacteria, which are 
major residents of the human intestinal flora, for arthritis-inducing properties. 
Lehman et aL [11] and Stimpson et aL [13] noticed that their CWF inducing chronic 
arthritis contained rhamnose as a major polysaccharide residue in common. This 
intriguing observation prompted us to investigate our bacterial CWF preparations for 
a relationship between rhamnose contents and the induction of chronic arthritis. The 
potency of bacterial CWF to induce a persistent chronic arthritis has also been related 
to the in vivo and in vitro resistance to lysozyme digestion [11,14]. This resistance to 
lysozyme digestion is essential for a prolonged presence of CWF in tissues and 
contributes to chronicity of the joint inflammation. The presence of rhamnose in the 
polysaccharide moiety may protect the bacterial cell wall against digestion in vivo by 
lysozyme. We tested our CWF preparations for in vitro sensitivity to lysozyme and 
compared these results with the CWF preparation's ability to induce arthritis. 
MATERIALS AND METHODS 
Animals 
Female Lewis rats (Olac Ltd, Bicester, UK), weighing 123-221 g were used 
throughout the whole study. Groups of 5 rats were injected i.p. with an aqueous 
suspension of CWF [7] from the anaerobic intestinal bacterial strains or with an equal 
volume of sterile phosphate buffered saline as a control. A cell wall dose of 25 J.Lg 
muramic acid per g of body weight has been chosen; some CWF were also tested at a 
dose of 50 J.Lg of muramic acid per g of body weight. The animals were observed for 
the development of paw inflammation at regular intervals during 60 days; diameters of 
wrists and ankles were measured with a vernier caliper 5 x in weeks 1 and 2, 3 x in 
weeks 3 and 4, 2 x in weeks 5 and 6 and once in weeks 7-9. 
Bacteria 
Eubacterium aerofaciens ATCC (American Type Culture Collection, Rockville, 
Maryland, USA) 25986, Eubacterium rectale, isolated from faeces of a healthy individual, 
Clostridium perfringens, originating from our laboratory strain collection, Clostridium 
ramosum ATCC 25582, Bifidobacterium breve ATCC 15700, Bifidobacterium adolescentis 
ATCC 15703 and Bifidobacterium strain M, isolated from a healthy individual, were all 
cultured on proteose-peptone broth (see below) or on Schaedler broth (Oxoid). 
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Lactobacillus fermentum 84.1253 was cultured on Schaedler broth (Oxoid) with pH 
adjusted to 6.1 prior to autoclaving; Lactobacillus leichmanii 84.609 was cultured under 
aerobic conditions on Todd Hewitt broth (Oxoid) supplemented with 0.3% (wjv) 
dextrose. Both Lactobacillus strains were gifts from the National Institute of Public 
Health and Environmental Hygiene, Bilthoven, The Netherlands. 
Proteose-peptone broth contains per liter: 20 g proteose-peptone (Oxoid), 1 g 
glucose, 3 g NaCl, 3 g ~HP04.3Hz0, 0.5 g KH2P04, 0.5 g MgS04.7HzO, 0.5 g 
cysteine-HCl, pH 7,2. All bacterial strains were cultured overnight at 37"C after 
inoculation with a log phase culture under strictly anaerobic conditions unless mentioned 
otherwise. Isolated strains were identified according to the methods of Holdeman et aL 
(15]. 
Preparation of cell wall fragments 
Bacterial CWF were prepared as described by Cromartie et al. [7] with minor 
modifications. Cells were harvested, washed and fragmented with glass beads in a Braun 
shaker (Melsungen, FGR); cell walls and intact cells were collected by 10.000 g 
centrifugation and treated again with glass beads if cell fragmentation was shown to be 
incomplete on microscopic examination of the Gram-stained cell wall suspension. Cell 
walls were treated with ribonuclease and trypsin, washed and sonicated (MSE, Crawley, 
UK) for 75 minutes. After sedimentation of debris, the sonicated cell wall suspension 
was passed through a 0.45 1.1.m millipore filter and tested for sterility. 
Chemical analysis of cell wall preparations 
Muramic acid and rhamnose contents were determined as described by Hadzija [16] 
and Dische and Shettles [17], respectively. The total amount of carbohydrate was 
determined according to Dubois et al. (18] with galactose as standard. 
Lysozyme digestion of bacterial CWF 
CWF suspensions were diluted in 0.1 M sodium acetate buffer pH 5.0 to an optical 
density of 560 nm (OD560) of about 0.8. Per mg dry weight CWF, 0.1 mg lysozyme (egg 
white, Sigma) was added, and during incubation at 37°C the OD560 was measured at 
regular intervals [14]. As a control, CWF suspensions were incubated at 37°C without 
the addition of lysozyme. 
Statistical analysis 
The mean increase of sum paw diameter from day 1-15 and day 16-60 after cell 
wall inoculation, compared with the sum paw diameter at the day of inoculation, was 
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taken as a variable for the severity of the acute and chronic arthritis, respectively. For 
each rat injected with the low CWF dose, the mean increase of sum paw diameter 
during the acute and chronic phase of the observation period was calculated; 
subsequently, the median value of these mean increases of sum paw diameters were 
calculated for each group of rats. The correlation between the median increase of the 
sum paw diameter and the rhamnose content of each CWF preparation in the nine 
groups of rats was evaluated for both the acute and chronic phase using the Spearman 
rank correlation test. 
Histology 
After 60 days, rats were sacrificed by cardiac puncture bleeding under ether 
anaesthesia. Skinned joint specimens were fixed in 1:10 (vjv) diluted buffered 36% 
formaldehyde solution, decalcified in 5% (v/v) formic acid for 5 days and embedded 
in paraffin. Specimens of liver tissue were fixed in the diluted formaldehyde solution. 
Sections were stained with hematoxylin and eosin. 
RESULTS 
Arthritis induction by CWF of 9 intestinal flora strains 
The results of i.p. injection of rats with bacterial CWF of intestinal flora strains 
are presented in Table 1. The low dose of E. aerofaciens CWF caused acute inflamma-
tion of the paws within 1-3 days, with swelling and redness of ankles, wrists, metacarpal 
and metatarsal regions. This acute inflammation increased, reaching its maximum 
intensity between days 8-12, then declined but relapsed at the end of the third week as 
chronic polyarthritis of moderate intensity which was still present at the end of the 
observation period (Fig. 1). Major joints of ankles and wrists, together with metacarpal 
and metatarsal joints were affected, but inflammation of digit joints was infrequently 
observed. At 6 weeks after i.p. injection, inflammation of a knee joint was seen in one 
out of five rats. During the first few days after CWF injection rats showed malaise, 
hemorrhagic conjunctivitis, rhinitis and sometimes diarrhoea. When the high CWF dose 
was given, a far more severe acute and chronic fulminant polyarthritis was observed with 
an increase in ankle diameter of more than 100% during the chronic phase. Rats 
inoculated with CWF of E. rectale showed minimal general disease during a few days, 
but failed to develop joint inflammation symptoms. 
CWF of both the Clostridium strains did not induce acute or chronic joint 
inflammation after intraperitoneal injection, even when the high cell wall dose was given. 
C. perfringens CWF appeared to be lethal within 24-48 hrs to half of the rats inoculated, 
whereas C. ramosum CWF had no toxic properties (Fig. 1). 
50 
45-.-----------------------, 45-.------------------------~ 
control E. aerofaciens 
0 10 20 30 40 50 60 0 10 20 30 40 50 60 
45-.-----------------------, 45-.-----------------------, 
B. adolescentis B. breve 
0 10 20 30 40 50 60 0 10 20 30 40 50 60 
45-.-----------------------, 45-.------------------------~ 
C. ramosum E. aerofaciens1 
0 10 20 30 40 50 60 0 10 20 30 40 50 60 
days after injection 
Figure L Inflammation induced in rat paws by the i.p. injection of bacterial CWF. Rats were inoculated at 
day 0 with a CWF dose of 25 Jl-g muramic acid /g body weight; the E. aerofacieni group was injected with 
the 50 Jl-g muramic acid /g body weight dose. Control rats were injected with an equal volume of PBS. 
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Table 1: Effect of i.p. injection of CWF of anaerobic Gram-positive bacteria from human faecal flora 
strains 
CWF from bacterium 
(strain) 
Eubacterium aerofaciens 
Eubacterium rectale 
Clostridium ramosum 
Clostridium perfringens 
Lactobacillus fennentum 
Lactobacillus leichmanii 
Bifidobacterium breve 
Bifidobacterium adolescentis 
Bifidobacterium strain M 
control 
5/5 
5/5 
5/5 
5/3 
5/3 
5/5 
5/5 
5/5 
5/5 
5/5 
25 f,tg muramic acid 
/ g body weight 
acute 
++ 
-I+ 
+/++ 
+/++ 
+ 
chronic 
+/++ 
+/++ 
++ 
+ 
Arthritis1 
50 f,tg muramic acid 
/ g body weight 
N/S 
5/5 
m3 
5/5 
5/2 
5/3 
NT 
NT 
NT 
NT 
acute chronic 
+++ +++ 
-I+ 
1
: arthritis insurviving rats: - absent, + mild, + + moderate, + + + severe. 
2
: number of injected rats/ number of surviving rats. 
3
: not tested. 
The results obtained after inoculating rats with L. fennentum CWF differed: one 
of 3 rats surviving the low CWF dose injection showed a mild acute arthritis, subsiding 
during the observation period, whereas 2 of the three rats which survived the high CWF 
dose injection developed a mild to moderate chronic persisting arthritis without a 
preceding acute arthritis. Rats inoculated with L. leichmanii CWF neither showed signs 
of paw inflanunation nor showed systemic disease after CWF injection. 
Bifidobacterium CWF injected rats showed a clinical pattern of paw inflanunation 
comparable to that observed in E. aerofaciens CWF inoculated rats. B. breve CWF 
injection resulted within 48 hrs in a moderately acute polyarthritis in three out of five 
rats followed by a moderate to severe chronic inflanunation of paw joints. Two rats did 
not develop signs of paw inflanunation (Fig. 1). CWF of B. adolescentis induced a mild 
to moderate acute paw inflanunation within 24-48 hrs after cell wall injection. These rats 
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gradually developed a moderate chronic polyarthritis, still active 60 days after cell wall 
inoculation (Fig. 1). One of these 3 rats showed also both knees inflamed near the end 
of the observation period. Rats which received Bifidobaderium strain M CWF developed 
a mild acute and chronic persisting arthritis. Control rats did not show signs of paw 
inflammation during the observation period. 
Biochemical composition of isolated CWF 
The muramic acid contents of the CWF preparations varied from 11 to 20% of 
dry weight (Table 2). The rhamnose contents of the cell wall preparations showed much 
more difference from one bacterial strain to another: some CWF contained no more 
than 1% rhamnose, whereas CWF from other strains contained up to 72% of their dry 
weight as rhamnose. The low contents of rhamnose, found in some cell wall preparations 
could not be explained by a low amount of cell wall polysaccharides, as shown by the 
results of the determination of the total amount of carbohydrates. Table 3 shows the 
actual dose of cell wall components for each bacterial strain and lists the resulting sum 
paw diameter increases during the acute and chronic phase of the arthritis. For the 9 
Table 2: Chemical composition and lysozyme sensitivity of cell wall preparations 
CWF from bacterium biochemical composition1 lysozyme 
(strain) sensitivitr 
muramic rhamnose total 
acid carbohydrate 
Eubacterium aerofaciens 16 31 82 31 
Eubacterium rectale 20 1 26 5 
Clostridium ramosum 21 72 103 1 
Clostridium peifringens 11 7 18 0 
Lactobacillus fennentum 15 2 55 61 
Lactobacillus leichmanii 15 <1 22 53 
Bifidobacterium breve 19 63 102 5 
Bifidobacterium adolescentis 11 43 49 15 
Bifidobacterium strain M 14 <1 74 0 
1
: results are given as percentages of dry weight. 
2
: expressed as the% decrease of the OD560 after 8 hrs incubation with lysozyme, compared with the 
OD560 at time zero. 
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Table 3: Actual CWF dose and resulting paw diameter increase 
Source of CWF cell wall dose1 increase 
paw diamete? 
muramic dry rhamnose total 
acid weight carbohydrates acute chronic 
E. aerofaciens 25 153 47 125 3.91 4.77 
E. rectale 25 128 1 33 0.58 0.78 
C. ramosum 25 117 84 120 -0.14 -0.24 
C. perfringens 25 235 17 42 -0.18 -0.69 
L. fermentum 25 172 3 95 0.39 0.36 
L. leichmanii 25 171 1 38 0.48 0.26 
B. breve 25 127 82 132 2.71 2.49 
B. adolescentis 25 224 97 111 4.18 7.48 
B. strain M 25 173 2 128 3.49 2.57 
1
: results given as Jl-g per g body weight. 
2
: results given in =· 
strains tested, the correlation between dose of rhamnose, the dry weight of CWF or the 
total amount of carbohydrates and increase of the sum paw diameters during both 
phases of the observation period were not statistically significant. 
Digestion of bacterial CWF by lysozyme 
After incubation with lysozyme, CWF suspensions of some bacterial species showed 
a decrease of the OD560 reaching a plateau at 8 h. The decrease in OD560 after 8 h, 
expressed as percentage of the OD560 at time zero, was taken as a variable for lysozyme 
sensitivity. This in vitro sensitivity of the CWF for lysozyme digestion showed great 
variation (Table 2): CWF from E. rectale, both Clostridium strains, B. breve and 
Bifidobacterium strain M were resistant to lysozymal degradation. CWF of E. aerofaciens 
and B. adolescentis were affected by lysozyme, whereas the Lactobacillus CWF were 
found to be rapidly digested by lysozyme. CWF suspensions without lysozyme added did 
not give a decrease of OD560 during incubation at 37°C (results not shown). 
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Histology 
Joint sections 
Sections from a hind paw joint of a rat, injected with E. aerofaciens CWF showed 
destruction of joint cartilage and underlying bone with replacement of joint space and 
adjacent tissues by connective tissue, resulting in fibrous ankylosis (Fig. 2a). Extensive 
apposition of new bone was seen; no foci with active inflammation were found. 
Sections from an arthritic hindpaw of a rat, injected with the L. fermentum high cell 
wall dose also showed extensive new bone formation. Some marginal cartilage erosions 
were seen and synovial lining appeared to be thickened and sometimes infiltrated, 
mainly with mononuclear cells. In joint spaces some inflammatory cells, predominantly 
polymorphonuclear, were found. A few circumscribed periarticular granulomatous 
inflammatory foci were found, characterised by the presence of histiocytes, mononuclear 
and polymorphonuclear cells and peripheral _fibrosis; multinucleated giant cells and 
central necrosis were not seen (Fig. 2b ). 
Infiltration of synovial tissue with both polymorphonuclear and mononuclear cells 
with some marginal cartilage erosions and pannus formation was seen in hind paw 
sections of rats, inoculated with B. breve CWF (Fig. 2c). Joint spaces and synovial 
sheaths showed the presence of predominantly polymorphonuclear cells with some 
macrophages and lymphocytes. Reactive bone formation in the marrow with numerous 
osteoclasts and prominent periosteal apposition of new bone were also seen. CWF of 
B. adolescentis induced prominent changes in joint structure: joint spaces and cartilage 
largely disappeared and were replaced by connective tissue. Polymorphonuclear cells 
were still seen in inflammatory foci. Sections showed periosteal apposition of new bone 
and an extensive turnover of bone with numerous osteoblasts, osteoclasts and some 
granulocytes. The bone marrow was also filled with reactive new bone. In contrast, joint 
sections of rats injected with Bifidobacterium strain M CWF showed an almost normal 
appearance with slight thickening of synovial lining cells and only a few inflammatory 
cells present in the synovium. No pathological changes of bone or cartilage were seen. 
Joints of rats, injected with E. rectale, Clostridium or L. leichmanii CWF, as well as 
joints of control rats did not show histopathological changes. 
Liver sections 
All 3 rats which developed chronic arthritis after inoculation with B. breve also 
showed characteristic liver pathology at day 60. The surface of the liver was covered with 
multiple small white-greyish tumors. Upon histological examination these appeared to . 
be circumscribed, non-caseous granulomas with multinucleated giant cells, histiocytes, 
lymphocytes and some polymorphonuclear cells (Fig. 2d); some of the granulomas 
showed central necrosis. The two rats without joint inflammation did not develop 
macroscopic liver disease. Rats, injected with CWF of E. aerofaciens, E. rectale, L. 
leichmanii, B. adolescentis and Bifidobacterium strain M did not show macroscopic liver 
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Figure 2. Histological appearance of tissue inflammation induced by bacterial CWF, 60 days after i.p. 
injection: 
(a) section through a hind paw of a rat, inoculated with a low CWF dose of E. aerofaciens, showing 
destruction of joint cartilage and underlying bone with replacement by fibrous tissue; magnification: 60 x; 
(b) section through a hind paw joint of a rat, injected with a high CWF dose of L. fermentum: two 
circumscribed periarticular granulomatous inflammation foci can be observed; magnification: 152 x; 
(c) section through a hind paw joint of a rat, injected with B. breve CWF: cartilage erosion and synovial 
inflammation can be seen; magnification 152 x; 
(d) section through the liver of a rat, injected with B. breve CWF: surrounded by liver cells, a circumscribed 
granuloma with several multinucleated giant cells can be seen; magnification: 239 x. 
pathology. Rats, inoculated with L. fennentum and Clostridium CWF had not been 
observed for liver disease. 
DISCUSSION 
Our study shows that CWF from E. aerofaciens and Bifidobacterium strains 
belonging to major residents of the human indigenous intestinal flora and occurring in 
numbers of 1010 per gram intestinal contents [5,19], induce a severe, longlasting arthritis 
in Lewis rats after a single i.p. injection. Other major residents such as E. rectale, L. 
leichmanii and Clostridium species failed to do so. These findings extend previous results 
showing the arthropathic properties of E. contortum isolated from the indigenous flora 
of a CD patient [9]. As these microorganisms occur in great numbers in the faecal flora 
of healthy individuals [5,19], these findings emphasize the relevance of the indigenous 
intestinal flora a~ a source of exogenous antigens possibly involved in joint inflammation, 
as recently was remarked by Saag and Bennett [20] and Inman [21]. 
Stimpson et al. [13] also investigated the arthropathic properties of cell wall 
polymers from normal flora bacteria using the same animal model. They discussed the 
hypothesis that the normal flora harbours a sufficiently diverse population capable of 
inducing a wide range of arthropathic responses in the host. They found that, among the 
limited number of strains tested, only Streptococcus faecium induced a persistent chronic 
arthritis. S. faecium, however, is a minor resident occurring in numbers less than 108 per 
gram intestinal contents, a hundredfold lower than the arthropathic E. aerofaciens and 
Bifidobacterium strains [5,19] used in this study. So, our results, showing a wide range of 
arthropathic properties present in several bowel flora bacteria, add substantial 
experimental evidence to their hypotheses. 
Lehman et' al. [11] and Stimpson et al. [13] suggested that induction of chronic 
arthritis is related to the rhamnose contents of the bacterial cell wall preparation. As 
peptidoglycan is· indispensable for induction of chronic arthritis [22,23] and because 
rhamnose appeared to be absent in some of our cell wall preparations, we adjusted our 
cell wall dose on its muramic acid contents instead of the rhamnose contents. This made 
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it possible to check the suggestion of Lehman and Stimpson, using the variable contents 
of rhamnose in the nine bacterial cell wall preparations. The data from our experiments 
grossly follow the suggested trend but, as the correlation found between rhamnose dose 
and the severity of the arthritis was not significant, we cannot give additional 
experimental support to their hypothesis. The heterogeneity of the tested bacterial 
strains, originating from several bacterial genera, may mask the possible relationship 
between rhamnose contents and chronic arthritis. 
Lehman et aL [11] also provided evidence that bacterial cell walls which are 
resistant to lysozyme may induce acute arthritis, but the cell walls must possess a 
polyrhamnose side chain on the peptidoglycan backbone to induce a chronic arthritis. 
The CWF of the 9 bacterial strains tested here offer a wide range of lysozyme 
sensitivities (Table 2), grossly following the formulated hypotheses, but with some 
intriguing exceptions. In the absence of cell wall rhamnose, the lysozyme resistant 
Bifidobacterium strain M CWF appeared to induce a mild chronic arthritis and the 
lysozyme resistant C. ramosum CWF, possessing rhamnose as major cell wall carbo-
hydrate, failed to induce a chronic arthritis. So, when CWF from several bacterial genera 
are studied, the relationship between arthropathic properties, lysozyme sensitivity and 
presence of cell wall rhamnose seems not to be as clearcut as was found by Lehman et 
aL [11] and Stimpson et aL [13]. It is probable that other cell wall characteristics also 
play a part in determining the arthropathic properties of bacterial CWF. As is known 
from the studies of Kohashi [22,24], peptidoglycan is the arthropathic cell wall 
component of the bacterial cell wall, with muramyldipeptide as the minimal cell wall 
structure able to induce joint inflammation in the rat. It is known that minimal 
differences in peptidoglycan composition and structure have a profound influence upon 
arthropathic properties of bacterial cell wall compounds. The amino sugar backbone of 
the peptidoglycan is an almost identical structure for all bacteria, b.ut the oligopeptide 
side chains show great variation [25]. Unfortunately, little information is available about 
the detailed composition and structure of the peptidoglycan and carbohydrate part of 
these anaerobic bacteria. Thus, a further explanation for the presence or absence of 
arthropathic properties of the tested bacteria would be highly speculative. 
Histological analysis of joint inflammation showed patterns which are in line with 
the findings of Cromartie et aL [7] for S. pyogenes CWF induced arthritis. The profound 
changes in bone structure induced by Bifidobacterium CWF have not been described 
previously and underline the potent arthropathic properties of these normal flora 
bacteria. Liver granulomas have been described after i.p. injection with streptococcal 
CWF [26], but were not seen in rats, inoculated with L. casei CWF [12]. The induction 
of liver granulomas by B. breve CWF suggests that these Bifidobacterium CWF and 
streptococcal CWF share mechanisms in tissue distribution and inflammation response. 
A local chronic granulomatous inflammation reaction upon local injection of streptococ-
cal CWF in the bowel wall was found by Sartor et al. [27]. However, S. pyogenes is not 
a major resident of the human faecal flora, whereas Bifidobacterium species occur in 
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high numbers in the human intestinal flora. Absorption of intestinal antigens is likely to 
occur on the basis of an increase in permeability of the bowel wall observed in patients 
with CD [6] reflected by the high incidence of serum antibodies to anaerobic coccoid 
rods found in patients with CD [10]. The presence of high numbers of granuloma-induc-
ing intestinal bacteria in the bowel lumen might well offer an explanation for the bowel 
wall granulomas found in CD and for the granulomatous rheumatoid noduli complicating 
RA. 
Clinical investigations show a relationship between infection with Gram-negative 
bacteria and joint disease: spondylitis ankylopoietica has been related to the presence 
of Klebsiella in the stool [28] and reactive arthritis to a Salmonella, Shigella or Yersinia 
infection of the bowel [3]. Recent observations demonstrate the presence of Yersinia 
antigens in synovial fluid cells of patients with reactive arthritis [29], and in a rat model 
the arthropathic properties of peptidoglycan structures from Neisseria gonorrhoeae are 
shown [30], whereas a role for LPS in induction and recurrence of arthritis in the rat 
model is established [31]. The presence of Yersinia antigens in synovial fluid cells 
together with the arthropathic properties of LPS and gonococcal peptidoglycan indicate 
the relevance of our rat model for the investigation of arthritis associated with Gram-
negative bacteria. Further investigations will be necessary to reveal the basis of the 
arthropathic diversity of CWF originating from intestinal flora bacteria and to elucidate 
the impact of these bacterial bowel flora antigens on the etiology of arthritis in man. 
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CHAPTER4 
CHRONIC ARTHRITIS INDUCED IN RATS BY CELL WALL FRAGMENTS OF 
EUBACTERIUM SPECIES FROM THE HUMAN INTESTINAL FLORA 
A.J. Severijnen, R. van Kleef, M.P. Hazenberg and J.P. van de Merwe 
Infect. Immun. 1990;58:523-8. 
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SUMMARY 
To investigate arthropathic properties of Eubacterium species, which are major 
residents of the human intestinal flora, cell wall fragments (CWF) of several Eubacte-
rium strains were prepared and tested in an animal model. After a single intraperitoneal 
(i.p.) injection in the rat, CWF of E. aerofaciens, E. contortum and E. lentum induced a 
chronic polyarthritis. E. limosum and E. tortuosum CWF induced an acute self-limiting 
joint inflammation, whereas E. rectale CWF failed to do so. The rhamnose contents of 
the isolated CWF were not related to their arthropathic properties. Paradoxically, the 
sensitivity of CWF to lysozyme digestion, which is regarded as a parameter for the 
clearance of CWF in tissues, appeared to be positively correlated with the ability of 
Eubacterium CWF to induce chronic joint inflammation. Our findings show the diversity 
in arthropathic properties among different species of the anaerobic genus Eubacterium 
and underline the importance of the anaerobic intestinal flora in the induction of joint 
inflammation. 
INTRODUCTION 
For several decennia, infectious agents have been implicated in the etiology of 
rheumatoid arthritis. However, it has not been possible to identify a particular 
microorganism responsible for the induction of this sterile joint inflammation. Several 
authors [1,12,16,18,19] impute an important role to the microbial contents of the bowel; 
bacterial products or components may pass the bowel wall, especially when the bowel 
wall has been damaged by infection or inflammation. The continuous influx of bacterial 
antigens triggers the immune system and may lead to the formation of immune 
complexes and deposition of poorly degradable bacterial compounds in joint tissues [20]. 
In susceptible individuals, a distortion of balance between the influx of bacterial material 
and the capacity of the body to clear this material may lead to accumulation of bacterial 
compounds in tissues, causing inflammation symptoms such as arthritis. 
In susceptible rats, a single i.p. injection of CWF from Streptococcus pyogenes or 
Lactobacillus casei causes an acute polyarthritis of paw joints followed by a chronic 
persistent arthritis [5,14]. We have adopted this animal model to study of arthropathic 
properties of anaerobic intestinal bacteria. Earlier reports [21,22] showed that CWF of 
Eubacterium and Bifidobacterium species have excellent arthritis-inducing properties. 
Eubacterium and Bifidobacterium species are Gram-positive major residents of the 
human intestinal flora, occur in high numbers (up to 1010 per g of faeces) in the bowel 
flora of healthy individuals [2,17], and thus add considerably to the load of bacterial 
antigens to which the immune system is exposed. On the other hand, CWF from other 
bowel flora species, e.g. Coprococcus, Peptostreptococcus and Clostridium species, fail to 
elicit chronic arthritis in rats. These large genus-dependent differences in arthropathic 
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properties may also be present between species of a single bacterial genus, as indicated 
by the profound difference in arthropathic properties of E. aerofaciens and E. rectale 
CWF, the latter failing to give any joint inflammation symptoms upon i.p. inoculation. 
Differences in arthropathic properties might be related to the biochemical 
composition of the bacterial cell wall, especially its rhamnose contents [15,26]; the in 
vitro resistance of bacterial CWF to digestion by lysozyme has been related to its ability 
to induce a chronic arthritis [15,27]. We have found that the relationships between 
arthropathic properties of CWF isolated from several anaerobic bacterial species and 
their lysozyme sensitivity and rhamnose contents are not as clear-cut as was concluded 
from experiments in which mainly Streptococcus and Lactobacillus CWF have been 
investigated [15,26,27]. As the CWF described in our previous paper [22] originated from 
several anaerobic bacterial genera, this heterogeneity may conceal the clear relationship 
found when modified streptococcal CWF were studied [27]. So, we have isolated and 
studied CWF from several strictly anaerobic species belonging only to the genus 
Eubacterium; the rhamnose contents as well as the susceptibility to in vitro lysozyme 
digestion of the CWF were investigated in relation to the ability of the CWF 
preparations to induce chronic arthritis after a single i.p. injection. 
MATERIALS AND METHODS 
Animals 
Female Lewis rats (Harlan Sprague Dawley, Bicester UK), weighing 109-197 gwere 
used throughout the study. Groups of four or five rats were injected i.p. with an aqueous 
suspension of the Eubacterium CWF [5]. A cell wall dose equivalent to 25 p.g muramic 
acid was given; control rats were injected with an equal volume of phosphate buffered 
saline (PBS). The animals were observed for the development of paw inflammation at 
regular intervals during 60 days; diameters of wrists and ankles at the distal end of the 
radius and at the malleoli, respectively, were measured with a vernier caliper five times 
in weeks 1 and 2, three times in weeks 3 and 4, two times in weeks 5 and 6 and one 
time in weeks 7-9. 
Bacteria 
E. aerofaciens ATCC 25986, E. contortum ATCC 25540, E. lentum ATCC 25559, 
E. tortuosum ATCC 25548, and E. limosum ATCC 8486 were obtained from the 
American Type Culture Collection, Rockville, Maryland, USA; E. rectale was isolated 
from the faecal flora of a healthy individual and was identified according to Holdeman 
eta!. [11]. All strains were cultured overnight at 37oc on Schaedler broth (Oxoid) under 
strictly anaerobic conditions after inoculation with a log-phase culture. For E. lentum, 
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the culture medium was supplemented with 5 g of arginine per liter [25]. 
Preparation of cell wall fragments 
Bacterial CWF were prepared as described by Cromartie et al. [5] followed by the 
differential centrifugation procedure given by Fox et al. [8]. Briefly, cells were harvested, 
washed, and fragmented with glass beads in a Braun shaker (Melsungen, FGR). Cell 
walls were collected by 10,000 g centrifugation, treated with ribonuclease and trypsin, 
washed, and sonicated (MSE, Crawley, UK) for 75 min. After sedimentation of debris, 
the sonicated cell wall suspension was centrifuged at 10,000 g for 30 min.; the 10,000 g 
supernatant was centrifuged twice at 100,000 g for 60 min. Both 100,000 g pellets were 
collected, resuspended in PBS and used for i.p. injection after passage through a 0.45-
ttm-poresize membrane filter (Schleicher and Schiill, FRG) and subsequent control for 
sterility. Two CWF preparations of the E. aerofaciens strain were made (Table 1 ), one 
with (A) and one without (B) the differential centrifugation procedure, by using the 
10,000 g supernatant after enzyme digestion and sonication. 
Chemical analysis of cell wall preparations 
Muramic acid and rhamnose contents were determined as described by Hadzija [10] 
and Dische and Shettles [6], respectively. The total amount of carbohydrate was 
determined according to Dubois et al. [7], with galactose as the standard. 
Lysozyme digestion of bacterial CWF 
CWF suspensions were diluted in 0.1 M sodium acetate buffer, pH 5.0, to an OD560 
of about 0.8. Per milligram of dry weight of CWF, 0.1 mg lysozyme (egg white, Sigma 
Chemical Co.) was added, and during incubation at 37°C the OD560 was measured at 
regular intervals [27]. As a control, CWF suspensions were incubated at 3TC without 
the addition of lysozyme. 
Statistical analysis 
The mean increase of the sum paw diameter from days 1-15 and days 16-60 after 
cell wall inoculation, compared with the sum paw diameter at the day of inoculation, was 
taken as a parameter for the severity of the acute and chronic arthritis, respectively. 
For each rat injected with the low CWF dose, the mean increases of sum paw diameter 
during the acute and chronic phase of the observation period were calculated; 
subsequently, the median value of these mean increases of sum paw diameter was 
calculated for each group of rats. The correlations between the median increases of the 
sum paw diameter and the doses of CWF, rhamnose, and total carbohydrate and the 
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lysozyme sensitivity in the seven groups of rats were evaluated for both the acute and 
chronic phase of arthritis by using the Spearman rank correlation test. To evaluate the 
increase of sum paw diameter in each rat group, the mean values of sum paw diameter 
of each rat during the acute and chronic phases of the observation period were 
compared with the values on day 0 by using the paired t test. 
Histology 
After 60 days, rats were sacrificed by cardiac-puncture bleeding under ether 
anaesthesia. Skinned-ankle joint specimens were fixed in 1:10 (v/v) diluted buffered 
36% formaldehyde solution, decalcified in 5% (v jv) formic acid for 5 days and 
embedded in paraffin. Specimens of liver tissue were fixed in the diluted formaldehyde 
solution. Sections were stained with hematoxylin and eosin. 
RESULTS 
Arthritis induction by CWF from Eubacterium species 
Table 1 lists the dose of Eubacterium cell walls given i.p. and shows the resulting 
changes in sum paw diameter during the acute and chronic phase of the observation 
period. In general, the Eubacterium species differed greatly in their arthropathic 
properties (Table 1; Fig. 1): CWF from some strains induced a persistent chronic 
arthritis of paw joints, whereas CWF from other strains failed to do so. The changes of 
the paw diameter during both periods after the cell wall injection were significant (P < 
0.05 [paired t test]) except in the E. rectale CWF rat group and in the control rats. E. 
aerofaciens A CWF, obtained after differential centrifugation, induced a more 
progressive chronic arthritis than E. aerofaciens B CWF, prepared without the additional 
centrifugation steps (P = 0.01 [Wilcoxon test]); results obtained with the E. aerofaciens 
B cell walls have already been presented [22]. E. contortum CWF induced an acute 
arthritis followed by a chronic joint inflammation; not all the animals were affected to 
the same extent. Rats inoculated with E. lentum CWF showed a late start of the chronic 
phase of the joint inflammation. After 60 days, the livers of these rats were covered with 
numerous small tumors (see below). These E. lentum CWF-injected rats showed general 
malaise during the whole observation period, whereas rats inoculated with other 
Eubacterium CWF showed malaise only during the first days after cell wall injection. 
CWF of E. tortuosum and E. limosum induced a self-limiting acute polyarthritis, whereas 
E. rectale CWF did not elicit joint inflammation symptoms in the inoculated rats. No 
mortality was seen after Eubacterium CWF injection. Control rats did not show 
macroscopic signs of paw inflammation. 
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Figure 1. Inflammation induced in rat paws by the i.p. injection of Eubacterium CWF; each line represents 
a single rat. At day 0, rats were injected with a CWF dose equivalent to 25 p.g muramic acid per g of body 
weight. The E. aerofaciens A and B CWF were prepared with and without the differential centrifugation 
procedure, respectively. 
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Table 1. Eubacterium cell wall dose and resulting paw diameter increase 
Source of CWF (n)a 
muramic 
acid 
E. aerofaciens A (5) 25 
E. aerofaciens B (5) 25 
E. contortum (5) 25 
E. lentum (5) 25 
E. tortuosum ( 4) 25 
E. limosum ( 4) 25 
E. rectale (5) 25 
control (5) 
a number of rats injected. 
b results given as J.Lg per g body weight. 
c results given in mm. 
d not determined. 
Amount of cell wall dose 
constituentb 
dry rhamnose 
weight 
304 95 
153 47 
141 44 
164 59 
184 10 
124 74 
130 2 
Biochemical composition of isolated CWF 
total 
carbohydrate 
269 
125 
167 
117 
NDd 
140 
33 
Increase of sum 
paw diameter< 
during phase 
acute chronic 
3.98 8.06 
3.91 4.77 
3.24 3.36 
0.99 3.66 
5.30 1.70 
1.39 1.12 
-0.17 -0.17 
0.68 -0.15 
The muramic acid contents of the isolated Eubacterium CWF varied from 8-20% 
of dry weight (Table 2); thus, peptidoglycan was the major cell wall component of the 
isolated cell walls. The rhamnose contents showed a greater range: in E. rectale CWF, 
rhamnose was almost absent, whereas 59% of the E. limosum CWF dry weight was 
rhamnose. Table 2 also lists the amount of total carbohydrate; because these results 
are based on galactose as the standard, a carbohydrate which may not be representative 
for the Eubacterium cell wall carbohydrate, the actual amount may be overestimated. 
Table 1 shows the actual dose of cell wall components in the Eubacterium strains 
injected and gives the severity of the joint inflammation, expressed as increase of paw 
diameter during the acute and chronic phases of arthritis. When the severity of the 
chronic arthritis, represented by the median value of sum paw diameters during days 15 
to 60 of the observation period, was compared with the rhamnose dose given to the 
seven rat groups, no significant correlation was found (r = 0.61, P = 0.16). Neither was 
there a significant correlation between acute arthritis and rhamnose dose (r = 0.18, P 
= 0.71), nor between the total carbohydrate dose and the severity of the chronic joint 
inflammation (r = 0.65, P = 0.18). 
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Table 2. Biochemical composition and lysozyme sensitivity of Eubacterium CWF 
Source of CWF 
E. aerofaciens A 
E. aerofaciens B 
E. contortum 
E. lentum 
E. tortuosum 
E.limosum 
E. rectale 
a results given in % of dry weight. 
Biochemical composition of CWF" 
muramic total 
acid rhamnose carbohydrate 
8 31 88 
16 31 82 
18 31 118 
15 36 71 
14 5 NDC 
20 59 112 
19 2 25 
lysozyme 
sensitivitY' 
69 
31 
44 
1 
8 
0 
0 
b results are given as the % decrease of the OD560 after 8 hrs incubation with lysozyme, compared with the 
OD560 at time 0. 
c not determined. 
Lysozyme sensitivity of Eubacterium cell wall preparations 
The percent decrease in OD560 after 8 h of incubation with lysozyme (Table 2) 
shows a major variance in the sensitivity of Eubacterium species to digestion by lysozyme. 
E. lentum, E. limosum and E. rectale CWF were not digested, whereas E. aerofaciens and 
E. contortum were clearly sensitive to lysozyme. E. tortuosum CWF were digested to a 
small degree. Incubation of CWF suspensions at 37°C without lysozyme added showed 
no decrease of OD560, except for the E. aerofaciens B CWF suspension, which gave a 
14% decrease of the OD560 after 8 hrs of incubation. No correlation was found when the 
sensitivity of the Eubacterium CWF for digestion by lysozyme was compared with their 
biochemical composition. A significant correlation was present between the sensitivity 
of the Eubacterium CWF and the severity of the chronic joint inflammation (r = 0.81, 
P = 0.02); regarding the acute arthritis, the relationship was not significant (r = 0.71, 
p = 0.08). 
Histology 
Hind paw sections of a rat, sacrificed 60 days after inoculation with E.aerofaciens 
A CWF showed active joint inflammation with swollen synovial lining cells and 
infiltration of subsynovial tissue with polymorphonuclear cells, lymphocytes and 
histiocytes (Fig 2a). The deeper layers of subsynovial tissue expressed a fibrous reaction, 
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Figure 2. Histological appearance of tissue inflammation induced by Eubacterium CWF 60 days after i.p. 
injection. (a) Section through a hind paw of a rat injected with E. aerofaciens CWF. Heavy infiltration of 
subsynovial tissue with lymphocytes, histiocytes, and some polymorphonuclear cells is markedly present. Also 
a marginal cartilage erosion with overlying pannus tissue can be seen. Magnification: 95 x. (b) Section through 
a hind paw of a rat injected with E. lentum CWF. Infiltration of subsynovial tissue with inflammatory cells 
and some synovial fibrosis are seen. Marginal cartilage erosions with osteoclasts are present, with pannus 
tissue invading the joint cavity. Some inflammatory cells are present in the joint space. Magnification: 48 x. 
with oedema, infiltration by lymphocytes and vascular proliferation. Heavily infiltrated 
spots alternated with areas with almost any inflammation, a phenomenon also seen in 
joint sections of rats inoculated with other Eubacterium CWF. Some marginal cartilage 
erosions were seen near infiltrated synovia. Periosteal apposition of new bone tissue was 
prominent. In ankle joints of rats injected with E. aerofaciens B CWF, no active 
inflammation foci were observed, but there was marked apposition of new bone and 
one of the major ankle joint spaces was partly replaced by connective tissue, resulting 
in joint ankylosis. Subsynovial tissue showed fibrosis; polymorphonuclear cells and 
lymphocytes were absent. Sections through an ankle joint of an E. contortum CWF-
inoculated rat showed gross disturbance of bone and joint architecture, with a marked 
apposition of new bone and an increased turnover of bone with the presence of multiple 
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osteoclasts. No cartilage or synovial tissue was found; probably this had been replaced 
by connective tissue, as was seen between metatarsal bones. 
Ankle joint sections of an E. lentum CWF-inoculated rat showed extensive joint 
inflammation: subsynovial infiltrations with mononuclear and polymorphonuclear cells, 
fibroblasts, numerous synoviocytes [30], histiocytes, vascular proliferation and some 
marginal cartilage erosions (Fig 2b ). Some joint spaces contained polymorphonuclear 
cells. Extensive apposition of new bone was present, with an increased bone turnover 
characterised by the presence of numerous osteoclasts. Some periarticular inflammatory 
foci were observed, mainly consisting of polymorphonuclear cells. liver sections of this 
rat showed numerous circumscribed fibrous granulomatous lesions; the sometimes 
necrotic centers consisted of polymorphonuclear cells and were surrounded by 
mononuclear cells, fibroblasts and histiocytes. The granulomas were distributed in a 
metastatic pattern. Multinucleated giants cells were seen in a minority of the granulomas. 
Joint sections of E. tortuosum CWF injected rats showed an extinguished 
inflammation: active inflammation foci were absent, while subsynovial tissue showed 
some fibrosis with an increase of small blood vessels; synovial lining cells were only 
slightly swollen; and no bone or cartilage changes were seen. 
Ankle joint sections of rats inoculated with E. limosum CWF showed comparable, 
but milder, synovial abnormalities. 
Neither joint sections of E. rectale CWF-inoculated rats nor those of control rats 
showed any pathology. 
DISCUSSION 
Species of the genus Eubacterium dominate the Gram-positive part of the human 
obligate anaerobic intestinal flora, representing up to 16% of the total bowel flora 
[2,17,28], which means that Eubacterium species occur at numbers of 6 x 109 per gram 
bowel content. This study shows that CWF from three of the six Eubacterium species 
investigated, i.e., E. aerofaciens, E. contortum and E. lentum induced a persisting chronic 
arthritis. Recently, Benno et a!. [2] showed that these strains were present in the faecal 
floras of healthy individuals, i.e., E. aerofaciens, E. contortum, and E. lentum in 29 of 30, 
3 of 30 and 8 of 30 healthy individuals, respectively; so, the selected strains are normal 
flora bacteria. 
CWF from the Eubacterium species show a spectrum of arthropathic properties, 
ranging from non-arthropathic (E. rectale) and self-limiting acute arthritis inducing (E. 
tortuosum and E. limosum) to persistent chronic polyarthritis inducing (E. aerofaciens, E. 
lentum and E. contortum ). The observation that E. tortuosum and E. limosum CWF 
induce a self-limiting acute joint inflammation proves that an initial acute joint damage 
is not necessarily followed by a chronic phase of joint inflammation. Histological sections 
of hind paw joints from E. tortuosum- and E. limosum-inoculated rats made after the 
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waning of the acute joint inflammation show synovial fibrosis, so the acute joint swelling 
must be based on a synovitis and is not merely a periarticular soft-tissue swelling. E. 
rectale CWF prepared without the differential centrifugation procedure lacked 
arthropathic properties [22]; the additional centrifugation step did not improve its 
arthritogenicity. Our findings underline the relevance of intestinal flora bacteria in the 
etiology of arthritis and extend previous observations that the large bowel harbours 
bacteria with a wide spectrum of arthropathic properties. 
According to histological examination of joint sections made 60 days after 
Eubacterium cell wall injection, three joint inflammation patterns can be distinguished. 
First, an active joint inflammation was still present at day 60, with infiltration of synovial 
tissue and reactive changes in bone and joint structure, as seen in rats injected with E. 
aerofaciens A and E. lentum CWF. Second, a subsided synovial inflammation was visible 
with gross proliferative changes in bone and joint structures. Obviously, the prolonged 
acute joint inflammation was extinguished, whereas the reactive bone destruction was 
still present, as observed in E. aerofaciens B and E. contortum injected animals. Third, 
after a self-limiting joint inflammation, minimal residual synovial abnormalities were still 
found, while bone and cartilage had a normal aspect, as can be seen in E. limosum and 
E. tortuosum injected animals. Thus, the arthritis patterns observed by measuring paw 
diameters (Fig. 1) agree with histological findings. 
It is known that CWF from S. pyogenes [29] and Bifidobacterium breve [22] are 
capable of inducing liver granulomas after a single i.p. injection [27]. Our finding that 
E. lentum CWF are also able to induce these liver granulomas emphasizes the property 
of CWF from anaerobic intestinal flora bacteria to induce a prolonged inflammation as 
a result of CWF persistence in tissues. 
Our previous report [22] shows that CWF from several bacterial genera differ 
greatly in arthopathic properties. Here we show that, when several bacterial strains from 
a single genus are examined, a similar variety in arthropathic properties can be seen. 
Arthropathic and non-arthropathic species may even occur within a single bacterial 
genus, as has been indicated by the differences in arthritis-inducing properties between 
CWF of the two E. contortum strains isolated from the flora of a patient with Crohn's 
disease [21]. 
To clarify the profound differences in arthropathic properties between Eubacterium 
species, we analyzed cell wall characteristics relevant to the bacterial cell wall model. 
As peptidoglycan is the essential arthritis-inducing cell wall component [4,5,8], we chose 
to establish our cell wall preparations on the basis of their contents of muramic acid, the 
characteristic building block of the amino sugar backbone of peptidoglycan. Several 
other cell wall factors are supposed to determine the arthritis-inducing property, i.e., 
CWF size [8], the integrity of the peptidoglycan-polysaccharide complex [ 4,5], the 
rhamnose contents of the cell wall [15,26], and the resistance of the cell wall to in vitro 
digestion by lysozyme [14,27]. Because our CWF isolation procedure results in intact 
peptidoglycan-polysaccharides with a limited spread in fragment size, we paid special 
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attention to the variable factors, rhamnose contents, and lysozyme sensitivity. 
Stimpson et al. [26] and Lehman et al. [15] observed a striking relationship between 
the rhamnose contents of bacterial CWF and their ability to induce a chronic arthritis 
upon i.p. injection. Our previous observations with CWF from bacteria of different 
genera followed the suggested trend but could not give significant support to their 
findings [22]. When CWF from several bacterial strains of the genus Eubacterium were 
tested, the correlation between rhamnose dose and severity of chronic arthritis appeared 
not to be significant. This indicates that rhamnose is not the major factor contributing 
to the arthropathic property of a given bacterial cell wall but is, together with lysozyme 
resistance, one of several cell wall properties which determine the joint inflammation 
properties of bacterial CWF. 
Stimpson et al. [27] found that the resistance of bacterial CWF to lysozyme is 
crucial for the ability of CWF to induce a chronic joint inflammation; in their study, they 
used chemically modified S. pyogenes CWF. In another study from Stimpson et al. [26], 
however, lysozyme-resistant CWF from Peptostreptococcus productus failed to induce 
chronic arthritis whereas Streptococcus faecium CWF, which were sensitive to lysozyme, 
did induce a chronic joint inflammation. Lehman et al. [15] showed that CWF from 
Lactobacillus plantarum and Lactobacillus fermentum, which were 20 and 97% degradable 
by lysozyme, respectively, and lysozyme-resistant CWF from L. casei did not induce 
chronic arthritis, whereas moderately degradable (5%) CWF from another L.casei strain 
induced severe chronic arthritis. In an earlier report on the arthropathic properties of 
CWF from several anaerobic bacteria [22], we already showed that the relationship 
between the ability to induce a chronic arthritis and lysozyme resistance is not clear-cut. 
The lysozyme sensitivity of Eubacterium CWF as given in Table 2 of the present study, 
demonstrates that CWF with good arthropathic properties were degradable by lysozyme, 
whereas CWF with poor or absent arthritis-inducing capacities were resistant to lysozyme 
digestion. 
We tried to fit the data discussed above into one general conclusion: a complete 
insensitivity or high sensitivity of CWF to lysozyme is related to an inability to induce 
chronic arthritis; a moderate sensitivity of CWF to lysozyme is related to the ability to 
induce arthritis. The present results agree with these conclusions. 
·In the adjuvant-induced-arthritis model it had been demonstrated that minimal 
changes in the peptidoglycan oligopeptide chains result in profound changes in 
arthropathic activity [3,13]. Information about these Eubacterium cell wall characteristics, 
which might be also relevant for the CWF model we used, is not available. Chemical 
analysis of the peptidoglycan structure of three Eubacterium species by Guinand et al. 
[9] and Severin et al. [23,24] shows great heterogeneity, which also might be present 
among the Eubacterium species described in this paper. In our laboratory, work is in 
progress to investigate peptidoglycan structure in more detail to relate bacterial cell wall 
composition to arthritis-inducing properties. 
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SUMMARY 
To study the arthropathic properties of human intestinal flora bacteria, cell wall 
fragments of the anaerobic bowel bacterium Eubacterium aerofaciens were intra-
peritoneally injected in arthritis-susceptible Lewis rats. At different stages of the 
subsequent polyarthritis, rat paw joints were studied for histopathological changes. A 
persisting synovitis was the hallmark feature, accompanied by marginal erosions of 
cartilage and bone and a marked periosteal apposition of new bone tissue. These results 
are discussed in relation to streptococcal cell wall-induced arthritis and compared with 
histopathological findings in rheumatoid arthritis in man. 
INTRODUCTION 
In susceptible rats, a single intraperitoneal (i.p.) injection of peptidoglycan-
polysaccharide complexes from some Gram-positive microorganisms induce an acute 
polyarthritis of paw joints followed by a chronic joint inflammation with exacerbations 
and remissions. This animal model has been described by Cromartie et al [1 ], using cell 
walls, cell wall fragments (CWF) and whole cells isolated from Streptococcus pyogenes 
group A. The CWF from Lactobacillus casei [2], group D Streptococcus faecium [3] as 
well as some other streptococci [1] also induce a persisting joint inflammation. 
This streptococcal cell wall (SCW) model is regarded as a valuable tool in the 
study of the pathogenesis of acute and chronic joint inflammation [4-6]. The polyarthritis 
induced by S. pyogenes CWF typically shows a biphasic course with a distinct histo-
pathological appearance [1,7,8]. In short: the acute phase is characterized by oedema of 
articular and periarticular tissues, infiltration by polymorphonuclear (PMN) cells, 
macrophages and a few lymphocytes, and synovial vasculitis [7,8]. After one week, the 
acute inflammation clinically [1] and histologically [7] wanes, but is followed by a chronic 
arthritis, characterized by exacerbations and remissions. In chronically infiltrated joint 
areas T-helper lymphocytes are the predominant cell type [7], accompanied by 
macrophages, fibroblast-like synoviocytes [9,10] and a few PMN cells. Tendonitis as well 
as apposition of new bone and marginal cartilage and bone erosions are seen from two 
weeks on [7]; the latter may lead to irreparable joint damage [1,7,8]. 
A microbial etiology of rheumatoid arthritis is strongly suspected [4-6,11,12]. The 
large bowel is a huge reservoir of microbial antigens to which the host is exposed 
[13,14]; bacterial compounds from the intestine may pass the bowel wall and be involved 
in induction or maintenance of chronic joint inflammation [4]. We adopted the SCW 
model to study the arthropathic properties of CWF from anaerobic Gram-positive 
bacteria isolated from the human intestinal flora. Reports from our group showed that 
CWF from Eubacterium and Bifidobacterium species, which are major residents of the 
human intestinal flora, can induce chronic joint inflammation in the rat after a single 
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i.p. injection [15-17]. A further study showed that E. aerofaciens was found in high 
numbers (i.e. >leY' per g faeces) in stool samples of all controls and RA patients studied 
[18]. In contrast, S. pyogenes has infrequently been found in the human intestinal flora 
[13,14]. CWF from isolated E. aerofaciens strains induced chronic arthritis [18]. In these 
studies, the chronic arthritis was confirmed histologically at day 60 after cell wall 
administration. 
We felt the need to follow the development of the E. aerofaciens induced arthritis 
throughout a prolonged observation period for a number of reasons. For studies on the 
mechanisms of pathogenesis e.g. by transfer of isolated lymphocytes [19] or vaccination 
[20] it is important to be well informed about the cellular events in vivo to evaluate the 
effect of intervention. Another reason for our detailed histological study of E. aerofaciens 
CWF induced arthritis is, that E. aerofaciens CWF as well as S. faecium CWF are clearly 
more sensitive to lysozyme than CWF of S. pyogenes [3,16,17,21]. As chronicity of joint 
inflammation has been related to antigen persistence in joint tissue [22] which is in tum 
supposed to be related to in vitro resistance to lysozyme digestion [21,23], the 
inflammation pattern of E. aerofaciens CWF induced arthritis. might differ from that 
induced by S. pyogenes cell walls. S. faecium CWF are known to induce a less persisting 
chronic joint inflammation than S. pyogenes CWF. Histological investigations, especially 
when performed during the chronic phase, may throw a light on this item. 
In the present paper, we report on the histological analysis of hind paw joint 
inflammation. At 8 moments during the acute and chronic phase, rats were sacrificed for 
histological studies. Moreover, we exceeded our previous observation period of 60 days 
with another 28 days to confirm chronicity of the induced joint inflammation. We also 
relate our observations to histological descriptions of S.pyogenes, S. faecium and L. casei 
cell wall induced arthritis. 
MATERIALS AND METHODS 
Animals 
Female Lewis rats (Harlan Sprague Dawley, Bicester, Oxfordshire, United 
Kingdom) weighing 100-172 g were used during the study. A group of 49 rats were given 
a single i.p. injection of an aqueous suspension of E. aerofaciens CWF. A cell wall dose 
of 25 JJ.g of muramic acid per g body weight was given; control rats were injected with 
an equal volume of phosphate buffered saline. The animals were observed for 
development of paw inflammation at regular intervals during 90 days. Diameters of 
wrists and ankles at the distal end of the radius and at the malleoli, respectively, were 
measured with a vernier caliper five times in weeks 1 and 2, three times in weeks 3 and 
4, two times in weeks 5 and 6, and one time in weeks 7-13. 
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Bacteria 
E. aerofaciens ATCC 25986 was obtained from the American Type Culture 
Collection, Rockville, Maryland, USA, and was cultured overnight at 37°C on Schaedler 
broth (Oxoid) under strictly anaerobic conditions after inoculation with a log phase 
culture. Bacterial CWF were prepared as has been previously described [18] according 
to Cromartie et al. [1] followed by the differential centrifugation procedure of Fox et al. 
[24]. Muramic acid and rhamnose contents of the CWF suspension were determined as 
has been described by Hadzija [25] and Dische and Shettles [26], respectively. The 
isolated E. aerofaciens CWF contained 15% (dry weight) muramic acid and 29% 
rhamnose. 
Histology 
At days 2, 5, 12, 21, 33, 47, 65 and 90 after cell wall injection, a group of 3 or 4 
rats was sacrificed for histological study. After cardiac puncture bleeding under ether 
anaesthesia, left hind paws were skinned and fixed in 1:10 (v/v) diluted buffered 
formaldehyde 36% solution, decalcified in 5% (v/v) formic acid for five days and 
embedded in paraffin. Sections of 6 J.Lm were stained with hematoxylin and eosin; some 
sections were stained with toluidine blue in order to identify mast cells. Of each paw 
joint about 30 sections, made at 3-4 levels, were evaluated for inflammation symptoms. 
RESULTS 
Induction of chronic arthritis 
The experimental group consisted of 58 rats, including 9 control rats injected with 
PBS. Of the 49 CWF injected rats, 35 developed a chronic arthritis; 5 rats died within 
24-36 h, whereas 9 failed to develop joint inflammation symptoms; the latter were 
excluded from histological analysis. Depending on the observation time, the 35 positive 
rats developed acute and chronic joint inflammation, with exacerbations and remissions 
during the chronic phase. The rats showed malaise, conjunctivitis and diarrhoea during 
the first days after i.p. cell wall injection. Fig. 1 gives an impression of the induced joint 
inflammation and shows the arthritis pattern of six rats which were observed for three 
months: 4 animals developed chronic persisting arthritis, one rat showed an acute self-
limiting arthritis whereas another rat failed to develop any joint inflammation symptoms; 
this rat was one of the 9 excluded from histological analysis. Control rats did not show 
any clinical signs of paw inflammation. 
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Figure 1. Inflammation of rat paws induced by the i.p. injection of E. aerofaciens CWF; each line represents 
a single rat. At day 0, rats were injected with a CWF dose equivalent to 25 J.Lg muramic acid per g body 
weight. 
Histology 
General findings during the development of the joint inflammation are summarized 
in Table 1. Synovial infiltration was present two days after cell wall injection and was 
found increased 5 days after cell wall injection; paw sections showed large articular and 
periarticular infiltrated areas (Fig. 2a). During the acute phase, PMN cells were the 
major cell type whereas after 2-3 weeks their predominance was taken over by 
lymphocytes. At the end of the observation period, tissue infiltration waned in some 
animals: in inflamed synovium and subchondral bone, infiltrated tissue had gradually 
been replaced by fibrotic connective tissue (Fig. 2f). In contrast, some other rats still 
showed active synovitis at day 90 (Fig. 2e). Differences in severity of inflammation 
between areas within a single paw section were found during the whole observation 
period. Focal proliferation of the synovial lining was a consistent feature of inflamed 
joints. ·synovial fibrosis increased during the chronic phase; tissue oedema disappeared 
after the first week following CWF injection. Synovial vasculitis was not observed during 
either the acute or chronic phase. Plasma cells were almost absent during the whole 
observation period. Mast cells were absent in inflamed synovial tissue, but were clearly 
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TABLE 1. Histopathology of joint inflammation induced by E. aerofaciens CWF 
days after cell wall injection 
tissue abnormalities 2 5 12 21 33 47 65 90 
synovial infiltration . +++ +++ +++ +/+++ +/++ -/++ ++ +++ 
PMN cells ++ +++ ++ + + + ± ± 
lymphocytes + + ++ ++ ++ ++ + + 
fibrosis ± + + ++ ++ ++ 
oedema ++ + + ± 
synovial lining + ++ ++ ++ ++ ++ ++ +/++ 
hyperplasia 
inflammatory cells + + + ± + + + ± 
in joint spaces 
cartilage and bone ± + + ++ ++ ++ ++ 
erosions 
periosteal apposition + + ++ ++ ++ ++ 
periarticular ++ +++ ++ ++ + + ± ± 
infiltration 
tendosynovitis + ++ ++ ++ + + + ± 
*: range;-: absent; +++:maximum severity. 
present in loose periarticular tissue. During the chronic phase, some inflamed joints 
showed pannus tissue extending into the joint cavity (Fig. 2a-c,e). Macrophages were 
consistently present in infiltrated synovial tissue; fibroblast-like synoviocytes appeared 
after 2-3 weeks in infiltrated synovium and were especially seen near marginal cartilage 
and bone erosions. A beginning of marginal cartilage erosion was already seen five days 
after cell wall injection (Fig. 2a), but was more obvious at day 12 (Fig 2b). During the 
observation period, erosions became more frequent and spread to underlying bone 
tissue. Osteoclasts and chondroclasts were seen adjacent to affected cartilage and bone 
tissue from day 5 on and were also present in infiltrated subchondral bone found near 
heavily inflamed joints (Fig. 2c). Periosteal apposition of new bone as well as 
periarticular development of new bone via chondroid tissue was observed from day 12 
on (Fig. 2d), and led in some animals to gross paw deformation. In some joint cavities 
PMN cells with macrophages and fibrin were found. 
83 

Figure 2. Histological appearance of hind paw inflammation induced by E. aerofaciens CWF. (a) Joint 
section of ankle, made 5 days after i.p. CWF injection. Oedema and infiltration of subsynovial tissue is seen, 
together with pannus formation and a slight affection of cartilage at the synovium-cartilage transition. The 
joint space contains some inflammatory cells; magnification: 155 x. (b) Day 12-section: less oedema and more 
fibrosis of subsynovial tissue is seen when compared to day 5. Marginal erosion of cartilage and underlying 
bone is apparent; magnification: 124 x. (c) Day 21-section: Extensive pannus formation, overlying the eroded 
joint cartilage, as well as numerous multinucleated chondroclasts are present. The joint space contains some 
inflammatory cells; magnification: 155 x. Day 90 sections: (d) Cortical apposition of new bone tissue with a 
rim of osteoblasts extending into the surrounding connective tissue is seen. The transition zone of cortical 
bone into new bone tissue is indicated by an arrow; magnification: 155 x. (e) Subsynovial tissue, heavily 
infiltrated with inflammatory cells, with swollen synovial lining cells are seen, together with marginal erosions 
of cartilage and bone tissue. Pannus is overlying joint cartilage; magnification: 155 x. (f) Extensive subsynovial 
fibrosis with few inflammatory cells is observed. Synovial lining cells are flattened; magnification: 124 x. 
In periarticular areas, oedema with infiltration by PMN cells and macrophages were 
observed in the acute phase. At the beginning of the chronic phase, oedema had 
disappeared but local infiltration was still continuously present; in some paw sections 
small circumscribed accumulations of lymphocytes were seen. Occasionally, focal 
accumulations of foamy cells were observed. Synovial or periarticular microabscesses 
could be observed during the first half of the observation period. Infiltration of tendon 
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sheaths by PMN cells and some macrophages was seen throughout the whole observation 
period. 
DISCUSSION 
The present study confirms our previous observations that E. aerofaciens CWF are 
able to induce an acute and chronic persisting polyarthritis in the Lewis rat [16,17]. 
Histopathological studies performed at several stages of the disease showed that a 
continuous synovitis is the hallmark feature, leading to cartilage and bone erosions and, 
finally, joint destruction. Our findings are grossly in line with the studies of Cromartie 
et aL [1] and Allen et al. [7] using streptococcal CWF and with observations of Lehman 
et al. using L. casei CWF [2], but they also reveal a few interesting dissimilarities. 
The erosions of marginal joint cartilage which we observed to start within two 
weeks following E. aerofaciens cell wall injection were also found in both S. pyogenes and 
L. casei injected rats [2,7]: evidence of early marginal erosions was reported to be 
present at day 10, but was more obvious at day 21. The presence of inflammatory cells 
in joint spaces was less abundant after E. aerofaciens CWF injection than seen after the 
administration of S. pyogenes cell walls. We did not observe vasculitis in synovial tissues, 
in contrast to observations in the S. pyogenes cell wall model [1,18]. Mast cells were 
found present in loose periarticular tissue but were almost absent in inflamed synovial 
tissue, a phenomenon also described in antigen-induced arthritis in mice [27]. A study 
in the streptococcal cell wall model also indicated a limited role for mast cells in the 
chronic phase of joint inflammation [28]. 
The biphasic pattern in arthritis induced by S. pyogenes CWF has been observed 
clinically [1] as well as microscopically [7]. However, we did not observe this phenome-
non in E. aerofaciens CWF induced arthritis. An explanation may be offered by 
differences in cell wall lysozyme sensitivity. Mter waning of the acute arthritis a release 
of CWF from tissue depots as liver, spleen and subchondral bone, together with the 
influx of T-lymphocytes, may lead to chronicity [7]. Due to an increased lysozyme 
sensitivity, the release of bacterial CWF from tissue depots may start earlier after E. 
aerofaciens injection than after streptococcal CWF injection, which results in a more 
continuous arthritis. This reasoning might also be applicable to S. faecium: the clinical 
symptoms of the joint inflammation induced by lysozyme sensitive S. faecium CWF were 
observed to turn smoothly into those of the chronic phase [3]. Unfortunately, the study 
of Stimpson et aL [3] gives too few details to permit the conclusion that also in S. 
faecium CWF induced joint inflammation this biphasic pattern is histologically absent. 
The arthritis induced by E. aerofaciens CWF shares some aspects with that induced by 
S. faecium CWF. Cell walls of both strains induce chronic arthritis without a biphasic 
pattern, characterized by few exacerbations and remissions, a chronic synovitis with 
marginal cartilage and bone erosions and formation of new bone tissue. Both S. faecium 
and E. aerofaciens CWF contain a reasonable amount of rhamnose (18 and 28% of dry 
weight, respectively) and are sensitive to in vitro digestion by lysozyme [3,17]. We 
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conclude that our results with E. aerofaciens CWF are well in line with observations 
made in S. faecium induced arthritis. 
Formation of new bone is an eye-catching feature in both SCW induced arthritis 
[1,7,8] and E. aerofaciens induced arthritis [16,17]. However, in the chronic phase of the 
L. casei model, small bone spurs adjacent to erosions were observed, but no evidence 
of significant periosteal new bone formation was present [2]; to date it is not understood 
why these arthropathic and lysozyme resistant [23] cell walls fail to induce marked new 
bone formation. 
When the histopathological findings in the rat model, obtained using S. pyogenes 
[1,7,8] or E. aerofaciens CWF, are compared with observations in human RA [29], 
similarities as well as dissimilarities come to light. Both joint inflammations share 
synovial infiltration by T-lymphocytes as a hallmark feature. Synovial lining hyperplasia, 
pannus formation, tendonitis as well as cartilage and bone erosions leading to joint 
destruction are seen in both rats and humans. The presence of PMN cells in synovial 
fluid is a feature of both RA and bacterial cell wall arthritis. In contrast to RA, synovial 
plasma cells as well as follicle-like accumulations of lymphocytes are almost lacking in 
the rat. The latter are pathognomonic for RA, but are found only in a minority of RA 
patients. In the chronic phase of the rat model bone apposition is marked, whereas in 
RA osteoporosis is seen. 
Part of the differences between RA and bacterial cell wall arthritis in the rat may 
be explained by differences in antigen exposure: in RA, an insidious exposure to a low 
dose of bowel derived bacterial antigens is hypothesized [4-6], whereas in the rat model 
the disease is elicited by a single, fairly high dose of bacterial cell wall fragments. The 
initial joint damage caused by this single cell wall dose may have a profound influence 
on the outcome of the chronic phase of the arthritis in the rat. Unfortunately, no 
information is available about the effect upon rat joints of a systemic administration of 
a low dose of bacterial cell walls during a long period. The acute joint inflammation 
induced by an intra-articular injection of streptococcal CWF can be reactivated by a 
systemic administration of homologous and heterologous cell wall polymers [29,30]. 
These observations contribute evidence to the hypothesis that a continuous influx of a 
low amount of bacterial cell wall does not lead to unresponsiveness to these bacterial 
antigens but even perpetuates joint inflammation. 
E. aerofaciens is found in high numbers in the human large bowel, exceeding 1<1 
per g faeces [13,14]; its cell walls have potent arthropathic properties, which share 
several histopathological features with RA These findings underline that bowel derived 
bacterial fragments may well be involved in chronic joint inflammation in man. 
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SUMMARY 
The composition of the obligate anaerobic intestinal flora of patients with 
rheumatoid arthritis (RA) differed from that of healthy subjects (HS). Total numbers 
of aerobes as well as anaerobic coccoid rods were found elevated when compared with 
HS. Eubacterium species were found in high numbers (i.e. > 1<f /g faeces) in all stool 
samples of both groups; Bifidobacterium species were present in 7 (RA) and 8 (HS) out 
of 10 subjects. From the flora of 2 RA patients and 2 HS Eubacterium species were 
isolated and identified. Cell wall fragments (CWF) from 4 E. aerofaciens strains (2 from 
RA, 2 from HS) were tested for arthritis induction in rats. All 4 strains induced chronic 
arthritis which was histologically confirmed. 
INTRODUCTION 
An etiological role for intestinal bacteria in rheumatoid arthritis (RA) has been 
proposed by Bennett [1] and was recently discussed by Midtvedt [2] and Phillips [3]. In 
some forms of sterile arthritis, the involvement of bowel bacteria has been established. 
The role of Salmonella, Shigella, Campylobacter and Yersinia in reactive arthritis is clear 
[4-6]; ankylosing spondylitis has been related to faecal carriage of Klebsiella [7] and in 
Reiter's disease, genito-urinary infection may be complicated by reactive arthritis, 
especially in HLA-B27 positive individuals [6]. 
In Crohn's disease (CD) and ulcerative colitis, bowel wall inflammation is 
complicated in about 20% by arthritis [8]. A microbial etiology in this arthritis is less 
clear but patients with CD show serum antibodies against anaerobic bowel bacteria [9] 
and have an abnormal faecal flora [10-12]. CWF from two Eubacterium contortum 
strains, isolated from a CD patient, induce chronic polyarthritis in rats after a single 
intraperitoneal (i.p.) injection [13]. These findings prompted us to investigate the 
composition of the intestinal flora of RA patients. 
Knowledge about the composition in RA of the most abundant group of intestinal 
bacteria i.e. the obligate anaerobes is not available. Shinebaum et aL [14] compared the 
faecal flora of RA patients with that of healthy controls but neglected the composition 
of the anaerobic flora, although anaerobes outnumber aerobes with a factor 100 in a 
normal flora [15,16]. They demonstrated a higher carriage rate of Clostridium perfringens 
in RA patients but found no other differences. An elevated number of C. perfringens in 
the stool of RA patients has also been described by Olhagen and Mansson [17], but 
could not be confirmed by other groups [18,19]. A recent report indicated that the 
jejunal flora may be altered in RA. With the use of jejunal aspirate cultures an 
abnormal jejunal flora was detected in 5 out of 17 RA patients; all 8 controls were 
negative [20]. Titres of anti-Proteus antibodies were found elevated in the sera of RA 
patients, in contrast to the level of anti-Klebsiella antibodies which did not differ from 
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that of controls [21]. 
Several authors have proposed a role for microorganisms in RA [1-3,22,23]. To 
date, no particular microorganism has been incriminated. The bacterial load from the 
intestinal flora as a whole may well be a trigger for autoimmune rheumatoid synovitis 
in predisposed individuals. As the anaerobes constitute more than 99% of the antigenic 
load of the bowel contents, we focus our investigations on this part of the indigenous 
flora. 
In this paper we deal with two questions: (1) does the anaerobic faecal flora from 
patients with RA differ from that of healthy individuals? and (2) does it contain species 
which have arthropathic properties? To test CWF of isolated bacterial species for 
arthropathic properties, we adopted the animal model described by Cromartie et al. 
[24]. Our previous studies showed that Eubacterium and Bifidobacterium CWF possess 
potent arthritis-inducing properties in this animal model [25,26]. In the present paper we 
compared the faecal flora of 10 RA patients and 10 HS; the faecal flora of two RA 
patients and two HS was examined for the occurrence of arthritis-inducing£. aerofaciens 
species. 
PATIENTS AND METHODS 
Ten RA patients were studied, 3 female and 7 male, aged 40-77 years with a 
median age of 62 years (Table 1 ). All patients were in-patients and fulfilled the 
American Rheumatism Association revised criteria [27]. From each subject, 2-3 stool 
specimens obtained at different days were investigated. During the study, one of the 
patients used sulphasalazine and another used amoxicillin with clavulanic acid. The 
control group consisted of 10 healthy subjects (HS), 5 females and 5 males, aged 26-46 
years, with a median age of 40 years. Control subjects, who were healthy laboratory 
volunteers had no joint symptoms or complaints and did not receive antibiotics during 
the period of stool culture. 
Anaerobic culture 
Stools were diluted and plated within 2 h after defaecation. Samples of 2 g were 
suspended in anaerobic broth with a Stomacher Lab Blender (Colworth, London, UK). 
Three serial 100-fold dilutions were prepared from the suspensions. The anaerobic 
diluent contained (per litre distilled water): tryptone (Oxoid), 5 g; glucose, 5 g; 
K2HP04.3Hz0, 3 g; KH2P04 0.5 g; NaCl, 5 g; cysteine hydrochloride, 0.5 g and resazurin 
(BDH), 0.002 g. The pH was adjusted to 7.2 and 100 ml volumes were sterilized for 10 
min at 121°C. From the final dilution of the stool sample, 0.2 ml was plated on a non-
selective solid medium for anaerobes (Schaedler broth, Oxoid, with 2% agar and 
0.0002% resazurin) and incubated at 37°C for 48 h. Anaerobic conditions were verified 
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Table 1. Composition, arthritis score and medication of the RA patients involved in this study 
Patient age 
A 56 
B 50 
c 77 
D 76 
E 72 
F 71 
G 40 
H 65 
41 
J 59 
1M: male, F: female. 
2RI: Ritchie index. 
ser 
M 
M 
M 
F 
M 
F 
M 
M 
F 
M 
RI2 medication 
16 NSAID, penicillamine 
14 NSAID, gold salt 
2 
2 NSAID 
10 NSAID, penicillamine, sulphasalazine 
2 azathioprine, costicosteroids, 
amoxicillin plus clavulanic acid 
10 NSAID 
8 NSAID 
3 NSAID, gold salt 
8 NSAID 
by using the indicator resazurin which becomes pink at a redox potential above - 120 
m V at pH 7.0 [28]. The surface of the solid medium was sufficiently large to enable 
development of 100 to 150 well-separated colonies. Gram stains of all colonies were 
made, and the number of isolates was multiplied by the dilution factors to give numbers 
per gram faeces wetweight. The composition of the flora was determined according to 
methods used in our previous studies on flora composition [10-12]. In short: the 
microorganisms were separated in following groups on basis of morphology and Gram 
characteristics: Gram-negative rods (Bacteroides and Fusobacterium) and Gram-positive 
Eubacterium or Bifidobacterium species, cocci and coccoid rods. More than ninety 
percent of the cultured organisms could be assigned to one of these groups. 
Aerobic counts 
Aerobic cultures were performed by plating appropriate dilution samples on sheep 
blood agar plates; colonies were counted after 24 h of incubation at 37°C. 
Identification of Eubacterium species 
Bacteria which were morphologically assigned as probable Eubacterium species 
were subcultured. Pure cultures were identified according to the system of Holdeman 
et al. [29]. The carbohydrate fermentation capacity was determined in peptone yeast 
extract medium (PY) with 0.05% L-cysteine-HCl, 0.0002% resazurin and 0.03% agar in 
sterilized (121°C, 15 min.) test tubes supplemented with 1% (w/v) of the following 
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filter-sterilized carbohydrates: amygdalin, arabinose, cellobiose, erythritol, esculin, 
fructose, glucose, glycogen, inositol, lactose, maltose, mannitol, mannose, melezitose, 
melibiose, raffinose, rhamnose, ribose, salicin, sorbitol, starch, sucrose, trehalose and 
xylose. A culture pH < 6.0 after 5 days of incubation was labeled as positive. The 
glucose fermentation products were determined by gas chromatography from 5-day 
incubates of the strains in PY broth with 1% glucose at 37°C under anaerobic conditions. 
Preparation of bacterial cell wall fragments 
The E. aerofaciens strains were cultured overnight at 37°C in Schaedler broth 
(Oxoid) under strictly anaerobic conditions after inoculation with a log phase culture. 
Bacterial CWF were prepared as described by Cromartie et aL [24] followed by the 
differential centrifugation procedure given by Fox et aL [30]. Briefly: cells were 
harvested, washed and subsequently fragmented with glass beads in a Braun shaker 
(Melsungen, FGR). Cell walls were collected by 10,000 g centrifugation, treated with 
ribonuclease and trypsin, washed and sonicated (MSE, Crawley, UK) for 75 minutes. 
After sedimentation of debris, the sonicated cell wall suspension was centrifuged at 
10,000 g for 30 min; the 10,000 g supernatant was centrifuged twice at 100,000 g for 60 
min. Both 100,000 g pellets were collected, resuspended in phosphate-buffered saline 
(PBS) and used for i.p. injection after passage through a 0.45 J.Lm millipore filter and 
subsequent control for sterility. 
Chemical analysis of cell wall preparations 
Muramic acid and rhamnose contents were determined as described by Hadzija 
[31] and Dische and Shettles [32], respectively. 
Lysozyme digestion of bacterial CWF 
CWF suspensions were diluted in 0.1 M sodium acetate buffer pH 5.0 to an OD560 
of about 0.8. Per mg dry weight CWF 0.1 mg lysozyme (egg white; Sigma Chemical Co., 
St. Louis, Mo., USA) was added, and during incubation at 37°C the OD560 was measured 
at regular intervals [33]. As a control, CWF suspensions were incubated at 37°C without 
the addition of lysozyme. 
Arthritis induction in rats 
Female Lewis rats (Harlan Sprague Dawley, Bicester, UK), weighing 143-195 g 
were used throughout the whole study. Groups of five rats were injected i.p. with an 
aqueous suspension of CWF from the E. aerofaciens species [24,26]. A cell wall dose 
equivalent to 24-27 J.Lg of muramic acid per g of body weight was given; control rats were 
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injected with an equal volume of PBS. The animals were observed for the development 
of paw inflammation at regular intervals during 60 days; diameters of wrists and ankles 
at the height of the distal end of the radius and at the malleoli, respectively, were 
measured with a vernier caliper five times in weeks 1 and 2, three times in weeks 3 and 
4, two times in weeks 5 and 6 and once in weeks 7-9. 
The mean increase of sum paw diameter from days 1-15 and days 16-60 after cell 
wall inoculation, compared with the sum paw diameter at the day of inoculation, was 
taken as a parameter for the severity of the acute and chronic arthritis, respectively. 
Histology 
After sixty days, rats were sacrificed by cardiac puncture bleeding under ether 
anaesthesia. Skinned paw joint specimens were fixed in 1:10 (v/v) diluted buffered 36% 
formaldehyde solution, decalcified in 5% (v/v) formic acid for five days, and embedded 
in paraffin. Sections were stained with hematoxylin and eosin. 
Statistical analysis 
The Mann-Whitney U-test was used to calculate the statistical significance of 
differences in composition of microflora groups of patients with RA and HS. 
RESULTS 
Composition of the anaerobic flora 
The composition of the faecal flora of 10 HS and 10 RA patients is shown in 
Table 2. Total numbers of anaerobes nor the composition of anaerobic flora did differ 
significantly between both groups, except the group of coccoid rods: these were found 
in higher numbers in RA patients than in control subjects (P = 0.003). Total numbers 
of aerobes were also significantly higher in the RA group (P = 0.0002). The two patients 
who used sulphasalazine or amoxicillin with clavulanic acid did not show major 
differences in flora composition when compared with other RA patients, except a higher 
number of aerobes. When these two patients were omitted from statistical comparison, 
the difference between HS (n = 10) and RA patients (n = 8) in coccoid rods was still 
significant (P = 0.01), whereas the difference in total aerobes was no longer significant 
(P = 0.08). 
In the faecal flora of both RA and HS, Eubacterium species were present in all 
samples and Bifi.dobacterium species in 7 out of 10 and in 8 out of 10 subjects, 
respectively. 
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Table 2. Composition of the anaerobic faecal flora of HS and RA patients 
Bacterial group Number of bacteria* 
Total anaerobes 
Gram negative 
Gram positive 
Eubacterium 
Bifidobacterium 
Cocci 
Coccoid rods 
Other 
Total aerobes 
HS (n=10) 
10.62 (10.47-11.37) 
10.40 (10.10-10.99) 
10.20 (9.94-11.11) 
9.52 (8.93-9.78) 
9.14 ( <8.00-10.76) 
9.61 ( <8.00-9.93) 
8.46 ( < 8.00-8.65) 
10.01 (9.74-10.84) 
6.88 ( 6.00-9 .27) 
* Log10 of median value and range per gram faeces (wet wt). 
RA patients (n=10) p 
10.76 (10.41-11.21) 0.47 
10.53 (9.97-11.06) 0.29 
10.13 (10.04-10.50) 0.20 
9.70 (8.98-9.96) 0.14 
9.16 ( <8.72- 9.82) 0.94 
9.76 (9.39-10.23) 0.09 
8.98 ( <8.56-9.32) 0.003 
9.75 (9 .40-10.32) 0.03 
8.40 ( <6.82-10.14) 0.0002 
Table 3. Identification of pure cultures of probable Eubacterium species selected from the flora of 2 RA 
patients and 2 HS 
Subject 
RA-1 
RA-2 
HS-1 
HS-2 
98 
Total number of probable 
Eubacterium species 
13 
12 
3 
5 
Identified as: 
9 Eubacterium aerofaciens 
2 Eubacterium lentum 
1 Eubacterium rectale 
1 Lachnospira multiparus 
3 Eubacterium aerofaciens 
3 Eubacterium rectale 
1 Eubacterium lentum 
1 Eubacterium ventriosum 
2 Peptostreptococcus intennedius 
1 Peptostreptococcus productus 
1 Ruminococcus a/bus 
3 Eubacterium aerofaciens 
2 Eubacterium aerofaciens 
3 not further identified 
Presence of E. aerofaciens in flora of RA patients 
The faecal flora of two RA patients and two HS was studied in detail. Colonies of 
bacteria morphologically belonging to the genus Eubacterium were subcultured and 
subsequently identified. Strains able to produce acid from fructose, glucose, lactose, 
maltose and sucrose and able to produce formic acid, acetic acid, lactic acid and ethanol 
from glucose were assigned to species E. aerofaciens. Otherwise, best fitting species is 
given. The results are presented in Table 3. We conclude that in the flora of patients 
with RA as well as from HS E. aerofaciens species were present. 
Arthritis induction in rats by cell walls from E. aerofaciens strains isolated from RA 
patients and HS 
CWF from 4 E. aerofaciens strains isolated from the flora of 2 RA patients and 2 
HS were tested for arthritis induction. The results are presented in Fig. 1 and Table 4. 
It is concluded that cell walls from all 4 isolated E. aerofaciens strains induced chronic 
arthritis. CWF from 3 of the 4 E. aerofaciens strains appeared toxic after i.p. injection: 
1 or 2 rats out of 5 died within 24-36 h. The severity of the paw inflammation differed 
between the individual rats of a group, a pattern which has also been observed in 
previous studies. All three rats injected with HS-1 CWF which survived the cell wall 
injection developed paw arthritis as well as an inflammation of one or both knees during 
the chronic phase of the observation period. Control rats did not show any sign of paw 
inflammation. 
Table 4. Cell wall dose, sum paw diameter changes after injection, and lysozyme sensitivity of isolated E. 
aerofaciens strains 
E. aerofaciens cell wall dose1 
strain muramic rham- dry 
acid nose weight 
RA-1 25 1 176 
RA-2 24 37 135 
HS-1 27 53 167 
HS-2 25 7 95 
control 
1expressed in Jtg per g rat. 
2number of rats injected/ number of rats survived. 
3 given in mm. 
N/S2 sum paw lysozyme 
diameter sensitivity4 
increase3 
acute chronic 
5/4 1.05 2.57 57 
5/4 2.17 2.17 33 
5/3 2.74 6.02 43 
5/5 2.95 2.49 41 
5/5 0.76 0.44 
4expressed as the % decrease of the OD560 after 8 h incubation with lysozyme, compared with the OD560 
at time zero. 
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Figure L Inflammation induced in rat paws by the i.p. injection of isolated E. aerofaciens CWF; each line 
represents a single rat. At day 0, rats were injected with a CWF dose of 24-27 J.Lg muramic acid per g body 
weight. The RA and HS strains were isolated from the faecal flora of RA patients and HS, respectively. 
We determined the rhamnose contents and the in vitro lysozyme sensitivity of the 
isolated CWF. The findings are shown in Table 4. Two of the strains contained low 
rhamnose whereas the other strains had fairly high amounts of rhamnose. Regarding the 
lysozyme sensitivity, the decrease in OD560 (Table 4) had reached a plateau after 8 h of 
incubation with lysozyme; CWF from all four E. aerofaciens strains were digested in vitro 
by lysozyme. 
Histology 
Of all four rat groups, 1-3 representative animals were studied for joint histology. 
All groups contained animals with one or more affected paws showing a characteristic 
joint inflammation pattern (Fig. 2). Articular and periarticular infiltration was found; 
synovial lining cells were swollen and occasionally the synovial lining showed hyperplasia. 
Synovial tissue was infiltrated predominantly with lymphocytes, synoviocytes [34] and, to 
a lesser extent, polymorphonuclear cells (PMN). Synovial fibrosis and vascular 
proliferation was less frequently observed. In some joint cavities, PMN and some 
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Figure 2. Histological appearance of joint tissue inflammation induced by bacterial CWF, 60 days after i.p. 
injection: (a) hind paw section of a rat, injected with E. aerofaciens HS-2 CWF. Synovial tissue is infiltrated 
by mononuclear cells; destruction of joint cartilage and underlying bone is seen; magnification: 53 x; (b) 
section through a front paw of a rat, injected with E. aerofaciens RA-2 CWF. Multiple synovial villi with 
swelling of lining cells are seen; synovial tissue is infiltrated by mononuclear cells. In the joint space, 
inflammatory cells (predominantly PMN) are found; magnification: 43 x. 
mononuclear cells were seen. Adjacent to inflamed synovium, erosions of cartilage and 
underlying bone were observed, with osteoclasts present. Within a single paw, both 
affected and unaffected joint tissue was observed. Periosteal apposition of new bone was 
frequently observed. Occasionally, as seen in a rat injected with E. aerofaciens HS-2 
CWF, extensive turnover of bone tissue with destruction of synovium and cartilage was 
markedly present. Tendon sheaths were also affected with swelling of sheath lining cells 
and infiltration of synovial tissue, predominantly by mononuclear cells. Some paw joints 
showed one or more periarticular foci consisting of lymphocytes. 
Within a single rat, not all paws were affected to the same extent. Grossly, when 
joint swelling was absent at day 60, no joint pathology was seen or only minor residual 
abnormalities as slight synovial fibrosis were found. When a major increase in paw 
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diameter was observed, as in rats inoculated with E. aerofaciens HS1 CWF, gross 
disturbances of joint structure were seen. Joints which were clinically moderately 
inflamed at day 60 showed active involvement of synovial, cartilage and bone tissue. 
Paw sections of control rats did not show any sign of joint inflammation. 
DISCUSSION 
Our investigations of the intestinal flora show some differences between RA 
patients and HS. Total numbers of aerobes as well as numbers of coccoid rods were 
found higher in RA patients. The patients and controls investigated by Shinebaum et aL 
were all outpatients; they found no differences in total numbers of aerobes between 
these groups [14]. The increase in total numbers of aerobes found in our RA patients 
is not likely to be caused by hospitalization [35] but may be due in part to the use of 
antibiotics by two patients. This is supported by the shift of P-values seen when the two 
patients on antibiotics were excluded from comparison. Sulphasalazine as well as 
amoxicillin plus clavulanic acid are known to have almost no effect on total numbers of 
the anaerobic intestinal flora [36-38]. We found that the total numbers of anaerobes did 
not differ between the groups, which is in line with findings of Shinebaum et al. [14]. 
The threefold increase in anaerobic coccoid rods in RA patients is not as impressive as 
the tenfold increase found in patients with CD [10], but is still intriguing. Serum 
agglutinins against anaerobic coccoid rods were demonstrated in a minority of RA 
patients, whereas CD patients showed these serum agglutinins more frequently [9]. In 
a rat model, the arthropathic properties of CWF from these coccoid rods were 
demonstrated [13]. The impact of the increased presence of coccoid rods in the faecal 
flora of RA patients remains unclear yet. 
We also showed that in the faecal flora of all investigated RA patients and HS 
Eubacterium-like species occur in numbers of 109 per gram faeces. Bifidobacterium 
species, if present, occur in the same numbers but were not detected (i.e. numbers < 108) 
in 3 RA patients and 2 HS. Careful isolation and identification of suspect Eubacterium 
species of four flora (2 RA and 2 HS) showed the presence of E. aerofaciens in each 
flora. The presence of E. aerofaciens and Bifidobacterium adolescentis in high numbers 
in the intestinal flora was described by Moore and Holdeman [15] and recently by 
Benno et aL [16]. 
Studies from our laboratory showed that CWF from representatives of the major 
residents of the obligate human intestinal flora such as E. aerofaciens and B. adolescen-
tis induced chronic arthritis in Lewis rats [25,26]. In these studies, strains of the 
American Type Culture Collection (ATCC) were used to .avoid doubts about correct 
identification. We have now demonstrated that CWF of 4 E. aerofaciens strains from 4 
subjects also induced chronic arthritis after a single i.p. injection in Lewis rats. Thus, 
E. aerofaciens strains isolated and subsequently cultured from individuals with a normal 
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intestinal flora as well as laboratory strain E. aerofaciens ATCC 25986 are arthropathic. 
Histological studies showed that the joint inflammation was comparable with our 
previous findings and in line with studies of Cromartie et al [24] on Streptococcus 
pyogenes CWF. We conclude that in the intestinal flora of RA patients and healthy 
individuals, E. aerofaciens strains are present with cell walls capable of inducing chronic 
arthritis in susceptible rats. It would be premature to conclude that the intestinal flora 
of RA patients itself is more arthropathic than the flora of HS; in our opinion, it is more 
likely that RA patients are more susceptible to the bacterial load originating from the 
bowel contents. 
In two previous papers [25,26] we discussed the hypothesis proposed by two groups 
using the same animal model [39,40], that the presence of cell wall rhamnose contributes 
to the arthropathic properties of bacterial cell walls. Our previous studies did not give 
additional experimental support to this hypothesis, neither do the present findings as 
given in Table 4. TheE. aerofaciens strains RA-1 and RA-2 induce chronic arthritis with 
similar severity, but the rhamnose contents of their cell walls differ greatly ( < 1% and 
27%, respectively). Obviously, the presence of rhamnose in the bacterial cell wall is not 
a prerequisite for its property to induce chronic joint inflammation, as the arthropathic 
E. aerofaciens RA-1 CWF contain little rhamnose. The present results agree with our 
previous observations that E. aerofaciens CWF are sensitive to in vitro lysozyme 
digestion. This supports our view, that in vitro lysozyme sensitivity is necessary for the 
induction of chronic arthritis [26]. 
Investigations of the influence of bowel flora bacteria on RA have to include 
studies on bacterial antigens in synovial tissues or fluids. Bartholomew and Bartholomew 
[41] demonstrated the presence of polysaccharides immunologically related to 
Propionibacterium species in synovial fluid and synovial leukocytes of RA patients. In 
RA, experimental evidence for the presence of bacterial compounds, e.g. muramic acid, 
in synovial tissue is lacking [42]. In reactive arthritis the presence of Yersinia and 
Salmonella antigens in synovial fluid cells has been recently demonstrated [4,5]. As 
stated by Christensson et al., it is premature to conclude that muramic acid is absent in 
rheumatoid joints since the detection method is too insensitive to demonstrate the small 
amounts of bacterial antigen that are immunologically relevant [42]. 
This report describes evidence indicating that the indigenous intestinal flora of 
RA patients differs from that of healthy individuals by an increased number of anaerobic 
coccoid rods and total number of aerobes. As the composition of the anaerobic faecal 
flora is known to be very stable over a long period of time [43], the increase in number 
of anaerobic coccoid rods in RA might be a characteristic feature and has to be 
confirmed, e.g. in a group of RA outpatients. From the flora of RA patients and healthy 
controls Eubacterium species have been isolated with arthropathic properties in an 
animal model. These findings add experimental evidence to the hypothesis that the 
bacterial load in the intestine may play a role in the etiology of RA 
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CHAPTER 7 
GENERAL DISCUSSION 
Previous reports have pointed to a possible role for bowel-derived bacterial cell 
wall compounds in induction or maintenance of chronic arthritis in man [1-3]. Studies 
directed to this aspect, however, have so far been limited to the aerobic intestinal flora. 
Since the anaerobic bacteria by far outnumber the aerobic bacteria in the intestinal 
flora, we have studied the arthropathic properties of cell wall fragments (CWF) from 
anaerobic intestinal bacteria. This was done in a rat model for chronic arthritis that has 
many features in common with human RA. 
CWF from two E. contortum species isolated from the faecal flora of a patient 
with Crohn's disease (CD) have been shown to induce chronic polyarthritis in Lewis rats 
after a single intraperitoneal (i.p.) injection (Chapter 2). P. productus CWF, on the other 
hand, induced a self-limiting acute arthritis, whereas C. comes CWF failed to induce any 
joint inflammation in the rats that survived cell wall injection. These findings show that 
the anaerobic intestinal flora of CD patients harbour arthropathic bacteria; these coccoid 
rods may play a role in bowel wall inflammation [4,5], but may also be involved in the 
joint complications associated with CD. 
In Chapter 3 we report on the arthropathic properties of a series of representative 
Gram-positive bacteria from the human anaerobic intestinal flora. We found that CWF 
of some Bifidobacterium species as well as E. aerofaciens CWF were able to induce a 
chronic joint inflammation in the rat, whereas CWF from E. rectale and L. leichmanii 
along with two Clostridium species gave neither acute nor chronic joint disease. Thus, 
the potency to induce chronic joint inflammation in the rat is limited to CWF of certain 
bacterial genera and species. This diversity in arthropathic properties was not only seen 
between various Gram-positive genera but was also observed within the various species 
of the genus Eubacterium (Chapter 4). 
It should be emphasized that these arthropathic anaerobic bacteria are normal 
inhabitants of the human bowel flora and have been found in numbers sometimes 
exceeding 108-109 per g faeces in the large bowel of healthy individuals [6-9]. Our 
findings (Chapter 6) have confirmed the ubiquitous presence of Eubacterium and 
Bifidobacterium species in the faeces of healthy individuals. These important groups of 
anaerobic Gram-positive bacteria were also found in high numbers in the faecal flora 
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of RA patients. Absolute numbers of Gram-positive anaerobic coccoid rods as well as 
absolute numbers of aerobic bacteria were found to be elevated in a group of 
rheumatoid arthritis (RA) patients, when compared with healthy subjects (HS). It is 
unknown whether a single species of the coccoid rod group (Eubacterium, Peptostrepto-
coccus, Coprococcus species) or the group as a whole is elevated. The significance of the 
elevated numbers of anaerobic coccoid rods in RA patients is not clear. As the intestinal 
flora of healthy individuals consists of about 1.5% anaerobic coccoid rods, the observed 
threefold increase in coccoid rods is not likely to result in an important increase in 
intestinal bacterial load. So, the minor differences in intestinal flora composition 
between RA patients and HS do not plead for a quantitative role for intestinal bacteria 
in RA, but might indicate a shift in flora composition from a non-arthropathic to an 
arthropathic combination of bacterium strains. As the resident faecal flora is determined 
by genetic factors of the host [10], the elevation of coccoid rods in RA might well be an 
expression of a genetic predisposition to RA. It is intriguing that also in CD these 
arthropathic anaerobic coccoid rods have been found in elevated numbers [11]. It has 
been established that E. aerofaciens strains isolated from the faeces of both RA patients 
and healthy individuals are capable of inducing chronic arthritis (Chapter 6). Taken 
together, it is clear that the intestinal flora of healthy individuals, as well as those of RA 
patients, harbour a number of anaerobic bacteria with cell walls capable of inducing a 
wide spectrum of paw inflammation after a single i.p. injection into rats. However, the 
significance of the changes in bowel flora composition found in RA patients is not clear 
yet. 
In Chapter 5, an extensive histological study of the joint inflammation induced by 
E. aerofaciens CWF was descnbed. We chose the latter bacterium because of its potent 
arthritis-inducing properties in the rat, and because this Gram-positive anaerobic 
bacterium is present in high numbers in the intestinal flora of nearly all healthy 
individuals [6,8]. In some rats, an active joint inflammation was still seen as late as 90 
days after cell wall injection. Paw joints inflamed due to i.p. E. aerofaciens CWF 
injection share several histopathological features with inflammation due to S. pyogenes 
[12-14] and S. faecium [15] CWF. Furthermore, this joint inflammation has several 
aspects in common with RAin man [16]. Cell wall properties of E. aerofaciens are more 
like those of S. faecium than those of S. pyogenes, which is apparent from the absence 
of a biphasic joint inflammation pattern and the in vitro sensitivity to lysozyme. 
Our results are an extension of previous studies by other groups in which mainly 
Streptococcus and Lactobacillus species were investigated [12,15,17,18]. These studies 
have contributed valuable information about pathogenetic mechanisms in chronic joint 
inflammation, but these bacterial species do not represent the human intestinal flora 
very well [6,8]. The same holds for the minor residents of the bowel flora used by 
Stimpson et aL [15]. Therefore it is questionable whether these studies are relevant with 
regard to the etiology of RA in man. 
The high number of bacterial genera and species tested permitted us to study 
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bacterial cell wall factors contributing to arthritogenicity. In two studies [12, 18] it was 
hypothesized that the presence of rhamnose contributes to chronicity of bacterial cell 
wall induced arthritis. Our findings showed several exceptions to this presumed 
association: for example C. ramosum CWF, which are high in rhamnose contents, failed 
to induce joint inflammation symptoms after i.p. administration (Chapter 3). No positive 
relationship was found between the rhamnose contents and the arthropathic properties 
when comparing several Eubacterium species (Chapter 4). Other experiments showed 
that four E. aerofaciens cell wall preparations with great differences in rhamnose 
contents all induced chronic joint inflammation (Chapter 6). So, our findings do not 
suggest that rhamnose enhances the arthropathic properties. We conclude that this 
hypothesis, originally based upon the study of some Streptococcus and Lactobacillus 
species, is not generally valid. 
We also studied the role of in vitro cell wall lysozyme sensitivity in the induction 
of chronic arthritis. It was hypothesized that cell wall resistance to lysozyme is a 
prerequisite for the induction of chronic arthritis [18,19]. Our observations presented in 
Chapter 3 do not support this hypothesis. On the contrary, from our results obtained by 
testing several Eubacterium species it became clear that cell wall sensitivity to lysozyme 
may even favour the chronicity of joint inflammation (Chapter 4). The divergent 
conclusions of Lehman et aL [18] and us may be based upon a different selection of 
bacteria. Lehman et aL based their hypothesis upon the investigation of a small number 
of bacterial genera i.e. Streptococcus and Lactobacillus; we found their hypothesis not 
valid for bacteria from a number of other genera. The question which cell wall factors 
determine or co-determine the arthropathic properties remains. 
Stimpson et al. [20] studied the fate of CWF in rat tissues, comparing 1251-labelled 
cell walls from S. pyogenes with those from S. faecium. They found that, in contrast to 
lysozyme resistant S. pyogenes CWF, the cell walls of S. faecium in liver and spleen were 
rapidly digested into smaller fragments. However, the amount of CWF in ankle and wrist 
joints did not differ between these bacterial species. Thus, although both Streptococcus 
species differ profoundly in cell wall lysozyme sensitivity [19], no difference in cell wall 
persistence in joint tissues was found up to 45 days after cell wall administration. These 
observations show that lysozyme sensitive S. faecium CWF do persist in joint tissues and 
are able to maintain a chronic joint inflammation after in vivo exposure to lysozyme. 
This observation is in harmony with the data presented in Chapter 4, in which we found 
a positive correlation between the in vitro sensitivity of Eubacterium cell walls to 
lysozyme and their potency to induce a chronic joint inflammation. 
In Chapter 4 it is suggested that the composition of the oligopeptide side chains 
of the peptidoglycan (PG) is an important factor in determining arthropathic properties. 
Studies of the adjuvant properties [21,22] and arthritis-inducing properties [23,24] of PG 
fragments have shown that slight variations in side chain composition have a profound 
influence on their biological activity. Recently, we demonstrated that a series of 
Eubacterium cell walls differed with regard to the amount of oligopeptide side chains 
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coupled to the muramic acid residues of the PG [25]. This, however, appeared not to 
be related to their capacity to induce chronic joint inflammation upon i.p. injection. 
Our findings that bacterial eWF from several Gram-positive anaerobic bowel 
bacteria induced persistent arthritis in the rat, give experimental support to the 
hypothesis that microbial compounds from the bowel contents are involved in chronic 
joint inflammation in man. Nevertheless, these results have to be interpreted carefully. 
Our observations have been made in a rat model. A long-lasting exposure to bacterial 
eWF from the gut, supposed to take place in RA, cannot be realized in the rat. In the 
rat model, an i.p. bulk dose of bacterial antigens probably results in a continuous release 
of these antigens from tissues. This might mimic a continuous influx of bacterial antigens 
from the bowel. However, it is unclear to what extent these conditions are comparable. 
Not all rat strains are susceptible to bacterial cell wall-induced arthritis [26], a 
situation similar to man. As only a minority of individuals exposed to their own bacterial 
flora antigens develop chronic joint inflammation, a genetic predisposition to RA is 
theorized. Indeed, RA is known to be related to some extent to the presence of the 
HLA-DR4 antigen [27]. 
It should be noted that the bacterial eWF preparations used in our animal model 
are not identical to the cell wall compounds which are liberated by growing and dividing 
bacteria [28]. Firstly, the soluble bacterial fragments present in faecal extracts [29] are 
derived from numerous bacterial species, in contrast to the eWF preparations used in 
our studies. Secondly, the peptidoglycan fragments liberated as a by-product of growing 
bacteria have a' smaller size (104 - 3 x 105 D) than eWF obtained by sonication of 
purified cell walls (up to 5 x 108 D) [28,30]. Sonicated eWF with a molecular weight 
higher than 5 X 106 D were arthropathic in the sew model, whereas PG complexes 
isolated from bowel contents were found not to be arthropathic after i.p. injection in 
the rat (unpublished results), probably due to their limited size. This does not exclude 
arthropathic properties, because, in the adjuvant arthritis model, the induction of 
arthritis was found less related to cell wall size [23,24] than in the sew model [30]. 
Thirdly, as several bacterial and host enzymes are present in the intestine [31,32], the 
soluble bacterial compounds present in the bowel contents will be subject to digestion 
by these enzymes. Thus, the bacterial compounds isolated from faeces would be expected 
to differ not only from eWF of cultured bacteria, but also from bacterial compounds 
isolated from the proximal part of the colon. 
Regarding the etiology of RA, bacterial antigens isolated from faeces are a more 
relevant antigen than eWF from cultured bacteria. Thus, bacterial cell wall compounds 
should be isolated from faeces as well as from the contents of the proximal part of the 
colon, characterized chemically, tested for arthropathic properties and compared to eWF 
obtained from cultured bacteria, in order to gain more insight into the still obscure 
relationship between chemical structure and arthrogenicity. Nevertheless, the study of 
arthropathic properties of mechanically disrupted bacterial cell wall fragments in the rat 
has given valuable information about the intrinsic inflammatory properties of bacterial 
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cell wall compounds. 
To gather additional experimental support for our hypothesis, it is of great value 
to investigate whether or not faeces-derived bacterial cell wall structures are present in 
joint tissues of RA patients. In patients with reactive arthritis, Granfors et aL 
demonstrated the presence of Yersinia [33] and Salmonella [34] antigens in synovial 
fluid (SF) cells using an immunochemical method. Pritchard et al., however, were 
unable to demonstrate muramic acid in SF cells of RA patients [35]. Christensson et 
al., using the same method (gas-liquid chromatography-mass spectrometry), could not 
detect muramic acid in some of their septic SF samples [36]. In contrast, with the 
biochemical assay of Sen and Kamovsky [37] muramic acid was detected in liver, brain 
and kidney tissue of naive rats. A chemical method has the disadvantage that bacterial 
compounds can be detected but not localized. Immunohistochemistry using monoclonal 
antibodies directed to PG structures outweighs this disadvantage, although cross-
reactivity between mammalian and bacterial antigens cannot be excluded. The 
application of both methods to synovial tissues of RA patients and controls should give 
valuable information about the presence and localisation of bacterial cell wall antigens. 
The histopathological studies described in Chapter 5 have given us more insight 
into the arthritis-inducing properties of E. aerofaciens cell walls and the changes of joint 
structures. We also performed this study to obtain more information about the sequence 
of cellular changes during the development of joint inflammation. However, not all 
relevant cell types involved in chronic arthritis can be identified with certainty by using 
decalcified and hematoxylin and eosin stained paw sections. The use of frozen joint 
sections stained with monoclonal antibodies directed against surface epitopes of involved 
cells would optimize the study of the localization and kinetics of T-lymphocytes and 
macrophages. Should a specific antibody directed to PG structures become available, the 
combination of these methods to localize both inflammatory cells and bacterial antigens 
would greatly clarify the relationship between inflammatory cells and peptidoglycan 
fragments in chronic joint inflammation. 
Summarizing, the data presented in the preceding chapters provide strong support 
for the supposition that CWF isolated from Gram-positive anaerobic bacteria from the 
human intestinal flora are involved in chronic joint inflammation in man. As the 
modifying role of cell wall rhamnose and lysozyme sensitivity in chronic arthritis is not 
supported by our studies, it still remains unclear which properties make bacterial cell 
walls arthropathic. As bacterial CWF might well differ from those present in bowel 
contents, intestine-derived bacterial cell wall compounds have to be investigated for 
chemical composition and arthropathic activity. Further studies should also deal with the 
occurrence of these bowel-derived PG complexes in rheumatoid joint tissues. 
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SUMMARY 
Rheumatoid arthritis (RA) is a systemic disease with chronic sterile polyarthritis 
as a major presenting symptom. It affects 1-2% of the population; its etiology is 
unknown. For several reasons, an infectious etiology is suspected, but the claims made 
for several microorganisms have not been convincing. It is hypothesized that the 
microbial load from the bowel contents may play a role in the induction or maintenance 
of joint inflammation. In the first chapter of this thesis, a general literature view on this 
hypothesis is presented. 
Observations in a series of bowel-related joint diseases gives support to this 
hypothesis: in Crohn's disease (CD) and ulcerate colitis, the bowel wall inflammation is 
complicated by joint inflammation symptoms in 5-23% of the cases. In bypass disease, 
which may follow the construction of a blind loop in the small bowel to promote weight 
loss, an arthritis occurs in about 20% of the cases, probably due to bacterial overgrowth 
in the blind loop. The finding that bowel infection by Salmonella, Shigella and Yersinia 
species may be complicated by joint inflammation symptoms also supports an etiological 
link between bowel bacteria and arthritis. 
The contents of the large bowel is characterized by the presence of a high number 
of microorganisms: up to 2 x 1011 bacteria per g faeces occur, and more than 99% of 
them are strictly anaerobic. The major cell wall component of Gram-positive bacteria 
is peptidoglycan; this amino sugar polymer has potent inflammatory properties such as 
the activation of complement and stimulation of lymphocytes and macrophages. 
Fragments of this peptidoglycan macromolecule are liberated during bacterial growth 
and division. It is supposed that these fragments pass the bowel wall during the lifelong 
exposure and are taken up by the immune system and transported to the joints and 
other tissues. As these bacterial cell walls are poorly degradable, a disturbance between 
influx and breakdown may cause peptidoglycan complexes to cumulate in joint tissues. 
In 1977, Cromartie et al. described an animal model for the study of arthritis. They 
isolated cell wall fragments (CWF) from Streptococcus pyogenes. After a single 
intraperitoneal injection of these cell walls, rats developed an acute polyarthritis of paw 
joints, followed by a chronic phase characterized by exacerbations and remissions. We 
adopted this model to study the arthropathic properties of CWF isolated from Gram-
positive anaerobic bacteria of the human intestinal flora. 
In the stool of patients with CD, Gram-positive anaerobic coccoid rods are found 
more frequently and in higher numbers than in the stool of healthy individuals. To study 
the role of the bowel flora in the joint complications in CD, we isolated CWF from four 
anaerobic Gram-positive coccoid rods. CWF from two of these, both being Eubacterium 
contortum strains, induced chronic arthritis in Lewis rats. These data are described in 
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Chapter 2. 
In Chapter 3 we describe the arthropathic properties of CWF from nine 
representative Gram-positive strains from the human anaerobic intestinal flora, strains 
which are present in high numbers (108-109 per g faeces, or even higher) in the stool of 
healthy individuals. We found a great variety in arthropathic properties, ranging from 
a persistent chronic arthritis (Eubacterium aerofaciens and Bifidobacterium species) to 
an absence of joint inflammation symptoms (Eubacterium rectale, Lactobacillus leichmanii 
and Clostridium species) after cell wall administration. This diversity was also seen when 
several species of the bacterial genus Eubacterium were studied (Chapter 4 ). Only minor 
differences in arthropathic properties were found between four isolated E. aerofaciens 
strains (Chapter 6). 
From studies using CWF of Lactobacillus species and S. pyogenes it has been 
hypothesized that the presence of cell wall rhamnose is necessary to induce a chronic 
joint inflammation. Another cell wall property, the in vitro cell wall resistance to 
lysozyme, is supposed to contribute to the persistence of CWF in tissues, leading to 
chronic joint inflammation. The large number of bacterial species investigated in our 
studies permitted us to test both hypotheses; our experimental results, however, did not 
support either hypothesis. CWF of the lysozyme resistant C. ramosum, for example, 
failed to induce chronic arthritis, even in the presence of cell wall rhamnose (Chapter 
3), whereas CWF from E. aerofaciens RA1, sensitive to in vitro digestion by lysozyme and 
without cell wall rhamnose, induced chronic joint inflammation after a single 
intraperitoneal injection (Chapter 6). It is not clear which factors account for the 
arthropathic properties of bacterial cell walls. 
The potency of E. aerofaciens CWF to induce chronic joint inflammation was 
histologically confirmed (Chapter 5). The acute phase was characterized by tissue 
oedema, synovial lining proliferation and infiltration of synovial tissue by polymorpho-
nuclear granulocytes, macrophages and some lymphocytes. In the chronic phase the 
synovial infiltrate contained more lymphocytes and less granulocytes; marginal cartilage 
and bone erosions as well as apposition of new bone tissue were characteristic features. 
In some rats, an active synovitis was observed up to 90 days after cell wall injection. This 
E. aerofaciens CWF-induced arthritis has many aspects in common with that induced by 
S. pyogenes and S. faecium CWF. Furthermore, several features are shared with RA in 
man, as the synovial infiltration, proliferation of synovial lining cells and marginal 
erosions of cartilage and bone. However, some dissimilarities were also found: in 
bacterial cell wall-induced arthritis, synovial plasma cells and follicle-like structures are 
almost absent, in contrast to RA 
Another way to study the involvement of the anaerobic intestinal flora in RA is to 
investigate whether or not the resident faecal flora of RA patients differs from that of 
healthy individuals. We found Eubacterium and Bifidobacterium present in the flora of 
both RA patients and healthy subjects; the number of Eubacterium and Bifidobacterium 
species did not differ, but the flora of 10 RA patients contained significantly more 
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anaerobic coccoid rods than the flora of 10 healthy individuals (Chapter 6). The impact 
of this increase in anaerobic coccoid rods in RA is not clear; an altered intestinal flora 
might be an expression of a genetic predisposition to RA. We also isolated E. aerofaciens 
strains from the intestinal flora of RA patients and healthy individuals; CWF from all 
4 strains isolated induced chronic arthritis in the rat after intraperitoneal injection. 
We conclude that the intestinal flora of healthy individuals and patients with RA 
harbour anaerobic bacteria with a wide range of arthropathic properties in the rat. These 
observations give experimental evidence to the hypothesis that the anaerobic intestinal 
flora is involved in the induction or maintenance of chronic joint inflammation. As our 
experiments have been performed in a rat model, and the bacterial cell walls used in our 
studies probably are not identical to bacterial cell wall compounds liberated in the 
intestine, our results have to be interpreted carefully regarding to RA in man. Chemical 
and arthropathic properties of bacterial cell wall compounds isolated from intestinal 
contents have to be compared to those of CWF from cultured bacteria. In addition, 
studies on the occurrence of bacterial cell wall compounds in joint tissues of RA patients 
may provide valuable experimental evidence that the bacterial load from the bowel is 
involved in chronic joint inflammation in man. 
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SAMENVA'ITING 
Reumatoide artritis (RA) komt voor bij 1-2% van de bevolking en heeft als 
belangrijkste kenmerk een chronische steriele ontsteking van een of meer gewrichten; 
de oorzaak is niet bekend. A1 een aantal decennia wordt gedacht aan een microbiele 
oorzaak, maar een specifieke verwekker kon tot dusver niet overtuigend worden 
aangetoond. Een hypothese is, dat bestanddelen van darmbacterien een rol spelen bij 
het in gang zetten of onderhouden van chronische gewrichtsontstekingen bij de mens. 
In het eerste hoofdstuk van dit proefschrift wordt vanuit de literatuur deze hypothese 
toegelicht. 
Klinische waamemingen waarbij een verband wordt gezien tussen gewrichtsontste-
kingen en darminfectie of ontsteking van de darm geven steun aan deze hypothese: bij 
een deel van de patienten met de ziekte van Crohn of colitis ulcerosa wordt de 
chronische ontsteking van de darmwand gecompliceerd door gewrichtsontstekingen. Ook 
patienten met vetzucht, bij wie de dunne darm kortgesloten is om gewichtsverlies te 
bevorderen, kunnen lijden aan gewrichtsontstekingen. Men vermoedt, dat bacteriele 
overgroei in de darmlis die buiten gebruik is gesteld, de oorzaak is van de gewrichtsont-
stekingen. Bij een klein deel van de patienten met een acute darminfectie door 
Salmonella-, Shighella- of Yersinia-bacterien treedt tevens een gewrichtsontsteking op. 
De inhoud van de dikke darm bestaat voor ruim 1/3 uit bacterien; van de meer 
dan honderdduizend miljard bacterien die voorkomen in een gram outlasting, leeft meer 
dan 99% in een zuurstofloos milieu ( = anaeroob ). Een belangrijk bestanddeel van de 
celwand van bacterien is peptidoglycaan: om de celmembraan heen ligt dit stevige 
netwerk van ketens van aminosuikers, die onderling verbonden zijn door aminozuren. 
Peptidoglycaan heeft ontstekingsbevorderende eigenschappen, zoals de stimulatie van 
witte bloedcellen en de activatie van complement. Groeiende en delende bacterien 
scheiden peptidoglycaanfragmenten uit; verondersteld wordt, dat deze bacteriele 
celwandbestanddelen de darmwand passeren, door het afureersysteem opgenomen 
worden en ook in de gewrichten terecht komen. Omdat de blootstelling aan dit slecht 
afbreekbare peptidoglycaan zeer langdurig is, kan het zich in gewrichten ophopen, met 
name in het geval van een verstoorde aanvoer of afbraak van dit bacteriele materiaal. 
In 1977 werd een proefdiermodel voor de studie van gewrichtsontstekingen 
beschreven. Celwandfragmenten van de bacterie Streptococcus pyogenes werden in een 
eenmalige dosis in de buikholte van Lewis-ratten geinjecteerd; de ratten ontwikkelden 
daarop acute gewrichtsontstekingen aan de poten, gevolgd door chronische ontstekingen 
die herhaaldelijk opvlamden en uitdoofden. We hebben dit model gebruikt om te 
onderzoeken of celwandfragmenten van anaerobe darmbacterien in staat zijn om 
gewrichtsontstekingen op te wekken. 
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In de darmflora van patienten met de ziekte van Crohn komt een bepaalde groep 
bacterien, de groep van de anaerobe coccoide staafjes vaker en in hogere aantallen voor 
dan bij gezonden. Om te bestuderen of deze bacterien betrokken zijn bij de gewrichts-
ontstekingen die bij de ziekte van Crohn voorkomen, hebben we celwanden van vier 
coccoide staafjes uitgetest in bet proefdiermodel. Ret bleek dat celwanden van twee 
Eubacterium contortum-stammen een chronische gewrichtsontsteking in de rat konden 
opwekken (hoofdstuk 2). 
Roofdstuk 3 beschrijft het uittesten in bet proefdiermodel van celwanden van 
negen bacteriesoorten die representatief zijn voor een belangrijk deel van de menselijke 
darmflora. We vonden grate verschillen: Eubacterium aerofaciens en Bifidobacterium-
soorten konden een chronische gewrichtsontsteking opwekken, terwijl celwanden van 
Eubacterium rectale, Lactobacillus leichmanii en Clostridium-soorten geen ontstekings-
verschijnselen opriepen. Oak tussen een aantal soorten binnen een bacteriegeslacht 
(Eubacterium) vonden we grate verschillen in bet vermogen om gewrichtonstekingen op 
te wekken, varierend van geen, aileen een acute of chronische, tot een acute en 
chronische gewrichtsontsteking (hoofdstuk 4). Vier stammen van dezelfde bacteriesoort 
(E. aerofaciens) bleken weinig te verschillen in hun vermogen om gewrichtsontstekingen 
op te wekken (hoofdstuk 6). 
Oak werd de relatie bestudeerd tussen eigenschappen van bacteriele celwanden en 
hun vermogen om een langdurige gewrichtsontsteking op te wekken. In de literatuur 
over bet gewri~htsontsteking-inducerende vermogen van celwanden van Lactobacillus-
soorten en S. pyogenes wordt de hypothese gesteld, dat de aanwezigheid van rhamnose 
in de bacteriele celwand nodig is om een langdurige gewrichtsontsteking op te wekken. 
Een tweede hypothese stelt dat bacteriele celwanden resistent moeten zijn tegen 
lysozyme om een langdurige gewrichtsontsteking te kunnen opwekken. Lysozyme is een 
van de weinige enzymen die in staat is de aminosuikerketens van bet peptidoglycaan te 
knippen en zo een essentiele bijdrage kan leveren aan de afbraak van peptidoglycaan 
in weefsels. Wordt bet peptidoglycaan in weefsels slecht afgebroken, dan is een 
langdurige ontsteking het gevolg. Onze experimentele bevindingen met een groat aantal 
bacteriestammen geven geen steun aan beide hypothesen. Zo geeft bijvoorbeeld E. 
aerofaciens stam RA-1 een chronische gewrichtsontsteking, ondanks een goede 
gevoeligheid voor lysozyme en de afwezigheid van rhamnose (hoofdstuk 6). Clostridium 
ramosum daarentegen leidt ondanks lysozyme-resistentie en een hoog gehalte aan 
rhamnose niet tot ontstekingsverschijnselen (hoofdstuk 3). Ret is niet duidelijk welke 
celwandeigenschappen bepalen of de celwanden van een bepaalde bacterie wei of niet 
een langdurige gewrichtsontsteking kunnen opwekken. 
Ret vermogen vanE. aerofaciens celwanden om een langdurige gewrichtsontsteking 
op te wekken werd oak histologisch bevestigd (hoofdstuk 5). De acute fase van de 
gewrichtsontsteking werd gekenmerkt door weefseloedeem, proliferatie van de synoviale 
bekleding en infiltratie van synoviaal weefsel door granulocyten, macrofagen en een 
aantallymfocyten. In de chronische fase bevatte het synoviale weefsel meer lymfocyten 
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en minder granulocyten. Op de overgang van synovia naar kraakbeen kwamen erosies 
van kraakbeen en onderliggend bot voor en op botvlies werd afzetting van nieuw bot 
gezien. Op dag 90 na celwandinjectie was er bij een deel van de ratten nog een aktieve 
ontsteking van de synovia waarneembaar. De gewrichtsontstekingen die werden 
opgewekt door celwandfragmenten vanE. aerofaciens, leken sterk op de gewrichtsontste-
kingen die ontstonden na injectie van S. pyogenes- en Streptococcus faecium-celwanden. 
Er is een aantal overeenkomsten met RA bij de mens, zoals infiltratie van synovium 
door lymfocyten en marginale erosies van bot en kraakbeen. Er zijn echter ook 
verschillen: in de gewrichtsontstekingen die worden opgewekt door bacteriele 
celwandfragmenten, ontbreken de synoviale plasmacellen en folliculaire lymfocyten 
aggregaten vrijwel geheel; dit in tegenstelling tot wat bij RA bet geval is. 
Vervolgens werd nagegaan of de anaerobe darmflora van patienten met RA 
verschilde van die van gezonden (hoofdstuk 6). Uit de darmflora van beide groepen 
werden Eubacterium- en Bifidobacterium-soorten geisoleerd. De totale aantallen 
Eubacterium- en Bifidobacterium -soorten verschilden niet, maar wel werd in de darmflora 
van een groep van tien RA-patienten een boger aantal anaerobe coccoide staafjes 
gevonden dan in de darmflora van tien gezonden. De betekenis van deze toename in 
aantallen coccoide staafjes bij RA is niet bekend; mogelijk is de afwijkende darmflora 
een uiting van een erfelijke aanleg voor RA. Ook werden uit de darmflora van twee RA 
patienten en twee gezonden E. aerofaciens-stammen geisoleerd die in bet proefdier-
model een langdurige gewrichtsontsteking konden opwekken. 
Ter afsluiting kan gezegd worden dat in de darmflora van zowel gezonden als 
patienten metRA anaerobe bacteriestammen voorkomen die een grote verscheidenheid 
aan gewrichtsontstekingen in de rat kunnen opwekken. Deze waarnemingen ondersteu-
nen de hypothese dat de anaerobe darmflora betrokken is bij bet ontstaan of 
onderhouden van chronische gewrichtsontstekingen bij de mens. Omdat de experimenten 
in een proefdier gedaan zijn en omdat de bacteriele celwanden die in deze studies 
gebruikt zijn waarschijnlijk niet identiek zijn aan celwandfragmenten die door groeiende 
en delende bacterien in de darminhoud uitgescheiden worden, moeten onze bevindingen 
met voorzichtigheid geinterpreteerd worden. Celwandfragmenten van gekweekte 
bacterien en celwandfragmenten geisoleerd uit faeces zouden moeten worden vergeleken 
wat betreft de chemische samenstelling en het vermogen om gewrichtsontstekingen op 
te wekken. Daamaast zou onderzoek naar bet voorkomen van bacteriele celwandbe-
standdelen in gewrichtsweefsel van patienten met RA steun kunnen opleveren voor de 
hypothese dat de darmflora betrokken is bij chronische gewrichtsontstekingen bij de 
mens. 
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LIST OF ABBREVIATIONS 
AS ankylosing spondylitis 
ATCC American Type Culture Collection 
CD Crohn's disease 
CFA complete Freund adjuvant 
CWF cell wall fragments 
EDTA ethylenediaminetetraacetic acid 
GF germfree 
HIA human leukocyte antigen 
HS healthy subjects 
i.a. intra-articular 
IL interleukin 
mn inflammatory bowel disease 
i.p. intraperitoneal 
IFA incomplete Freund adjuvant 
i.v. intravenous 
kD kiloDalton 
LPS lipopolysaccharide 
MDP muramyldipeptide 
MHC major histocompatibility complex 
NSAID non-steroid anti-inflammatory drug 
PBS phosphate buffered saline 
PEG polyethylene glycol 
PG peptidoglycan 
PG-PS peptidoglycan-polysaccharide 
PMN polymorphonuclear cells 
PS polysaccharide 
PY peptone yeast extract medium 
RA rheumatoid arthritis 
S.C. subcutaneously 
sew streptococcal cell walls 
SF synovial fluid 
SPF specific pathogen-free 
uc ulcerative colitis 
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